RXcelebs
 
877-RX-CELEBS info@rxcelebs.com REQUEST MORE INFO
   
HOME WHO WE ARE WHAT MAKES US UNIQUE OUR SERVICES OUR CLIENTS OUR WORK INDUSTRY NEWS
 
CONTACT US
 
Home > NewsIndustry News > Healthcare Updates
  Medworm
The 3 D's of Pharma Digital Marketing
Tue, 07 Jun 2016 12:30:57 +0100
This article is a review of the e-book entitled Pharma 3D: Rewriting the script for marketing in the digital age." (Source: Pharma Marketing News)
Multi-Channel Cross-Cultural Marketing
Tue, 07 Jun 2016 12:30:36 +0100
This article describes how Boehringer Ingelheim teamed up with with Univison in a ground-breaking campaign to drive awareness for Type 2 Diabetes through story-line integrations in the original production, Bajo el Mismo Cielo. (Source: Pharma Marketing News)
Estimating Pharma's Digital Ad Spending
Tue, 07 Jun 2016 12:29:35 +0100
Elusive Data Wrapped in a Mystery Inside an Enigma Trying to determine what portion of pharma's total marketing budget is devoted to digital and if that portion is increasing, is a daunting task. (Source: Pharma Marketing News)
Brave New World of Off-Label Marketing
Wed, 16 Mar 2016 12:05:45 +0100
This article summarizes various scenarios for how the FDA, courts, and independent 3rd-parties may influence off-label drug promotion in the future. (Source: Pharma Marketing News)
TV DTC Advertising Is Not Dead Yet!
Wed, 16 Mar 2016 12:05:34 +0100
But Lawmakers, Politicians, & FDA are Aiming for the Head The big jump in DTC advertising & high cost of drugs have resulted in calls for a total ban of DTC advertising or the elimination of tax deductions for DTC advertising. And the FDA is planning a bevy of studies, which may lead to new guidelines. (Source: Pharma Marketing News)
Cute & Creepy DTC Drug Ad Mascots
Wed, 16 Mar 2016 12:05:03 +0100
This article features our all-time favorite drug ad mascots. (Source: Pharma Marketing News)
Digitally Savvy Women Pharma Pioneers
Tue, 19 Jan 2016 12:04:57 +0100
Show Support: Bring Them Into the Forefront! Pharmaguy put together a list of "Digitally Savvy Women Pharma Pioneers." You can find out who they are and more about them in this article. (Source: Pharma Marketing News)
2015 Was a Golden Year for Pharma
Tue, 19 Jan 2016 11:16:37 +0100
This article explains why. (Source: Pharma Marketing News)
2016 New Year's Resolutions for Pharma
Tue, 19 Jan 2016 11:15:57 +0100
How to Be Less Like Martin Shkreli These are my New Year's Resolutions for the drug industry and especially pharmaceutical marketers. (Source: Pharma Marketing News)
Pharma Marketing: The Year 2015 in Images
Wed, 09 Dec 2015 12:08:41 +0100
Pharmaguy's Favorite Images with Commentary from Pharma Marketing Blog, Pharma Marketing News, and Scoops. (Source: Pharma Marketing News)
Anti-DTC Resurgence
Wed, 09 Dec 2015 12:08:22 +0100
This article explores this issue. (Source: Pharma Marketing News)
How to Achieve Digital Pharma Marketing Results
Wed, 09 Dec 2015 12:07:39 +0100
This article focuses on digital disruption, which is the focus of a chapter in the book RESULTS: The Future of Pharmaceutical and Healthcare Marketing written by by R.J. Lewis (aka RJ) et al. (Source: Pharma Marketing News)
The Power of Patient Input
Thu, 10 Sep 2015 11:05:54 +0100
This article presents a case study of how patient input has the power to change the course of drug approval. The case is Sprout's ground-breaking patient campaign that played a major role in getting Addyi, a female sexual dysfunction drug, approved by the FDA. (Source: Pharma Marketing News)
Pharma's Use of Medical Conference Twitter Hashtags
Thu, 10 Sep 2015 11:05:47 +0100
This article discusses the pros and cons of safeguards proposed a group of academic physicians (the #MICEproject) to limit pharmaceutical 'detailing' and to 'bring the medical community closer to establishing guidelines for third party activities in Twitter back-channels.' (Source: Pharma Marketing News)
Celebrities + Social Media
Thu, 10 Sep 2015 11:04:29 +0100
This article focuses on the risks and benefits of using celebrities and social media to promote pharma brands and proposes that it may be time for the pharma industry to disclose the details of payments made to celebrities as they now are required to do for physician payments. (Source: Pharma Marketing News)
One Billion Dollars! O Valeant!
Wed, 02 Sep 2015 17:24:35 +0100
Sung to tune of O Canada Shortly after the FDA approved Addyi (the "pink pill"), Canadian pharma company Valeant announced it would buy Sprout for $1 billion. Was it a good buy? (Source: Pharma Marketing News)
Lilly's "Intermittent Wiper" Moment
Mon, 24 Aug 2015 17:25:34 +0100
Accused of Stealing Drug Adherence Tool In its latest legal saga, the drugmaker is going head-to-head with a woman who claims that Lilly stole her idea for a tool that helps patients' remember to take their meds. Plaintiff Lisa Duer filed a complaint alleging that Lilly at first tried to license her patented "Take-n-Slide" adherence gadget. But after the negotiations fell through, Lilly and its supplier, Bensussen Deutsch & Associates, simply copied Duer's idea instead, the suit claims. This has all the dramatic BIG CORPORATION vs little guy overtones as in the 2008 movie Flash of Genius, which focuses on Robert Kearns and his legal battle against the Ford Motor Company when they developed an intermittent windshield wiper based on the inventor's ideas. Except that intermittent wipe...
His and Hers Hand Towels Monographed with Viagra and Addyi Logos
Mon, 24 Aug 2015 17:24:04 +0100
Only $20! Overview * Handmade item * Materials: terry cloth, sildenafil citrate, flibanserin, microcrystalline cellulose, etc. * Only ships to United States (Source: Pharma Marketing News)
FDA's Unbridled 96% New Drug Approval Rate
Mon, 24 Aug 2015 17:22:36 +0100
A New Record! Remember when the FDA rejected drugs? As recently as 2008, companies filing applications to sell never-before-marketed drugs, which are referred to by the FDA as "new molecular entities," faced rejection 66% of the time. Yet so far this year the FDA has rejected only three uses for new chemical entities, and approved 25, an approval rate of 89%. In reality, the FDA approval rate is more like 96%. (Source: Pharma Marketing News)
The Mobile Health Library
Fri, 26 Jun 2015 13:15:35 +0100
Apps for Rx Adherence & Outcomes Support Rob Dhoble, CEO of Adherent Health, is interviewed about his company's Mobile Health Library™ (MHL) mHealth platform, which is built specifically for the education and support of patients and caregivers. MHL offers many features for creating cost-effective mobile apps for Rx brand adherence and outcomes support. (Source: Pharma Marketing News)
Wearables, Ingestibles, Implantables
Fri, 26 Jun 2015 13:15:20 +0100
This article discusses the intrusiveness of wearables et al and other issues of these technologies as they relate to healthcare outcomes and communications arena and whether pharma marketers should get on the bandwagon. (Source: Pharma Marketing News)
Leveraging Multi-Channel Infographics for Patient Support
Fri, 26 Jun 2015 13:14:56 +0100
#DareTo Say SUDEP Case Study In this article, Maureen Winigrad and John Griffith, principals at Centric Infographics, present the latest access data for the "Epilepsy & Seizures: Facts to Keep You Safe" infographic campaign and discuss the new SUDEP campaign in more detail. (Source: Pharma Marketing News)
The Patients Included Initiative & Pharma
Tue, 26 May 2015 15:57:21 +0100
This article discusses that issue and suggests that the pharmaceutical industry, which claims to be "patient centric," can play a role by sponsoring Patients Included scholarships similar to how they sponsor physician continuing medical education programs for physicians. (Source: Pharma Marketing News)
Pharma Marketing Buzzwords
Tue, 26 May 2015 15:56:47 +0100
This article summarizes the results of that survey. (Source: Pharma Marketing News)
PharmaPhobia & What to Do About It
Tue, 26 May 2015 15:56:14 +0100
This article reviews some of Stossel's main arguments. You be the judge. (Source: Pharma Marketing News)
A KOL by Any Other Name
Fri, 17 Apr 2015 12:04:57 +0100
This article summarizes the results of the KOL Name Change Survey and discusses how to change the underlying process by which pharma companies choose KOLs. (Source: Pharma Marketing News)
The Debut of the Chief Patient Officer
Fri, 17 Apr 2015 12:04:41 +0100
This article summarizes the roles of Chief Patient Officers in bringing the patient perspective into their company's work. Sanofi is used as a case study. (Source: Pharma Marketing News)
DTC Ad Spending Rises From the Grave
Fri, 17 Apr 2015 12:04:06 +0100
This article presents the data and discusses Pfizer's leading role in the DTC ad resurgence, especially in regard to TV advertising, which accounts for almost 70% of all DTC advertising dollars. (Source: Pharma Marketing News)
Patient Centricity, Transparency, & Pharma's Reputation
Thu, 19 Feb 2015 17:33:11 +0100
This article discusses real world examples of patient-centricity in pharmaceutical marketing and the need for more transparency in how pharmaceutical companies partner with patients online. (Source: Pharma Marketing News)
The Consumer Brief Summary
Thu, 19 Feb 2015 17:32:49 +0100
This article summarizes the new guidelines and reviews the need for additional guidelines that specifically address the fair balance section of DTC print ads. (Source: Pharma Marketing News)
The Next FDA Commissioner Will Be...
Thu, 19 Feb 2015 17:32:30 +0100
Industry Pundits Think It's a Shoe-In. Do You? In a new survey, Pharma Marketing News asks your opinion about who should be the next FDA commissioner. The survey has been seeded with the candidates mentioned in this article. You can choose one of these or enter your own choice. (Source: Pharma Marketing News)
2014 Was a Good Year for FDA & Pharma
Tue, 13 Jan 2015 16:02:41 +0100
Banging Year for Drug Approvals, Wimpy Year for Enforcement Actions The FDA approved a total of 41 new molecular entities (NMEs) and biologics (BLAs) in 201 4but sent out only a meager 10 advertising enforcement letters in 2014, the fewest ever. (Source: Pharma Marketing News)
The Year 2014 in Images
Tue, 13 Jan 2015 16:02:21 +0100
Pharmaguy's Favorites from Pharma Marketing Blog In this article, Pharmaguy presents the best images from Pharma Marketing Blog, which cover topics of importance in 2014: DTC and drug promotion spending, drug risks and adverse events, drug industry reputation, FDA and social media regulatory guidelines, mobile apps, and drug development costs. (Source: Pharma Marketing News)
2015 New Year's Resolutions for Pharma
Tue, 13 Jan 2015 16:02:01 +0100
Focus on Mobile, DTC, Patients, Prices, etc. Here's John Mack's list of 2015 resolutions for pharmaceutical marketers. Hopefully, at least one of these will be kept, although no one is making any promises. (Source: Pharma Marketing News)
FDA To Study DTC Promotion Directed at Adolescents
Fri, 12 Dec 2014 12:26:47 +0100
This article is a review of that study, which aims to assess how adolescents interpret drug risk in DTC advertising. (Source: Pharma Marketing News)
Does Your Spouse Influence Your DTC Viewing Experience?
Fri, 12 Dec 2014 12:26:40 +0100
FDA Wants to Peek Into Your Bedroom FDA's Office of Prescription Drug Promotion (OPDP) plans to examine differences between consumers viewing prescription drug ads with a spouse versus alone. Study: "Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements" (Source: Pharma Marketing News)
Are Drug.com Websites "Fair and Balanced?"
Fri, 12 Dec 2014 12:25:02 +0100
This article reviews the study "Examination of Online Direct-to-Consumer Prescription Drug Promotion" (FDA-2011-N-0230), which is designed to test different ways of presenting prescription drug risk and benefit information on branded drug Web sites. (Source: Pharma Marketing News)
Boehringer Ingelheim Receives the 2014 PharmaGuy Social Media Pioneer Award
Wed, 29 Oct 2014 19:07:42 +0100
Global Social Media Team Tweet Chats, Engages, & Tells All This year's Pharmaguy Social Media Pioneer Award went to the Boehringer Ingelheim (BI) Global Social Media Team, which includes Patricia Alves, Social Media Community Manager, Jaclyn Fonteyne, Social Media Specialist, and their boss, Judith von Gordon, Head of Media + PR. (Source: Pharma Marketing News)
A Formula for Patient-Centric mHealth Apps
Wed, 29 Oct 2014 18:25:07 +0100
This article summarizes the comments from a "debate" within the LinkedIn Mobile Health Group and a #mHealthPharma TweetChat and condenses the learnings into one simple formula for creating quality pharma mHealth apps. (Source: Pharma Marketing News)
Correcting Independent 3rd-Party "Misinformation" About Prescription Drugs
Wed, 29 Oct 2014 18:12:06 +0100
This article summarizes the industry's response to the second guidance document regarding correcting and/or responding to misinformation related to a firm's own FDA-approved products when that information is created or disseminated by independent third parties on the Internet or through social media. (Source: Pharma Marketing News)
Drug Industry Rips Into FDA Over Social Media Guidelines
Tue, 30 Sep 2014 19:16:39 +0100
This article summarizes some of the main points made by PhRMA, Washington Legal Foundation (WLF), BIO, Medical Information Working Group (MIWG), Patient, Consumer, and Public Health Coalition, and several pharmaceutical companies, regarding FDA's Draft Guidance on using Internet and social media platforms with character space limitations. (Source: Pharma Marketing News)
Podcast: A "Comuniti" for Healthcare Professionals
Tue, 30 Sep 2014 19:15:50 +0100
Univadis in France Gets Social "Contact your colleagues and talk exclusively with health professionals. Work with your colleagues in public or private groups. Ask medical questions and find precise answers." These are the capabilities offered by "Comuniti," a new online community launched in early 2014 as part of MSD France's Univadis service exclusively for healthcare professionals. Thibaud Guymard, Digital Marketing Manager at MSD France talks about Comuniti, a new online community that is (Source: Pharma Marketing News)
Online e-Patient & Celebrity Patient Video Testimonials
Tue, 30 Sep 2014 19:14:28 +0100
This article asks the question: Can anecdotal "evidence"/experiences mentioned in patient videos -- even unbranded videos -- cause unnecessary visits to the doctor's office and over prescribing of drugs with serious side effects? (Source: Pharma Marketing News)
More FDA Guidance on Distribution of Reprints
Tue, 30 Sep 2014 19:10:35 +0100
Presenting "New Risk Information" About Drugs to HCPs On June 6, 2014, FDA issued a THIRD guidance document regarding reprint distribution by pharmaceutic companies: "Distributing Scientific and Medical Publications on Risk Information for Approved Prescription Drugs and Biological Products - Recommended Practices." This new document describes FDA's recommendations for distributing reprints that convey "new risk information" for approved drugs. (Source: Pharma Marketing News)
Patient Storytelling Marketing
Sun, 31 Aug 2014 15:10:11 +0100
Creativity vs. Truth in Pharma Advertising These days, patient storytelling is all the rage. More often than not, however, patient stories told by pharma marketers are not 'providing truth' in the sense that they are real patient stories. (Source: Pharma Marketing News)
Patient Activists Demand Higher Quality Mobile Health Apps
Sun, 31 Aug 2014 15:09:29 +0100
Pharma Must Listen, Respond, and Optimize! Sooner or later Congress, perhaps urged on by patient advocates or some mhealth app adverse event, may investigate the mobile health app industry -- including the drug industry -- to see if further oversight, not just FDA regulations, is required. Before that happens and to ensure that mobile health apps developed by pharma are of the highest quality, the industry should differentiate itself from "wild west" developers by being pro-active in developing and abiding by a set of 'Guiding Principles for Mobile Health Apps.' (Source: Pharma Marketing News)
FDA Sets Up a Roadblock for Branded Rx Promotional Tweets
Tue, 01 Jul 2014 09:52:46 +0100
This article reviews the FDA's guidance on how pharma marketers must present both benefit and risk information within a "promotion" of FDA-regulated medical products via electronic/digital platforms that are associated with character space limitations: e.g., Twitter. The review also looks at the feasibility of "workarounds" such as Twitter Cards. (Source: Pharma Marketing News)
FDA Tweet Blocks Pharma
Mon, 30 Jun 2014 15:55:45 +0100
This article reviews the FDA's guidance on how pharma marketers must present both benefit and risk information within a "promotion" of FDA-regulated medical products via electronic/digital platforms that are associated with character space limitations: i.e., specifically through social media such as Twitter and through online paid search (e.g., "sponsored links" on search engines such as Google and Yahoo). The review also includes some ideas on how pharma marketers may be able to use Twitter for branded Rx messages and still be compliant with the new FDA guidelines. (Source: Pharma Marketing News)
How to Host a Successful Pharma TweetChat
Mon, 30 Jun 2014 15:55:31 +0100
This article reviews BI's "playbook" -- titled "How pharma TweetChats can drive healthcare innovation" -- which provides detailed insights for planning and delivering successful pharma TweetChats. The authors of the playbook -- Patricia Alves, Social Media Community Manager, and Jaclyn Fonteyne, Social Media Specialist, at BI -- were also interviewed for this article. (Source: Pharma Marketing News)
FDA Tells Pharma How to Correct Online Misinformation
Mon, 30 Jun 2014 15:54:42 +0100
This article reviews the FDA's guidance on how pharmaceutical companies can respond to misinformation related to a firm's own FDA-approved or -cleared products when that information is created or disseminated by independent third parties on the Internet or through social media, regardless of whether that misinformation appears on a firm's own forum or an independent third-party forum or website. (Source: Pharma Marketing News)
Survey: Distribution of Off-Label Reprints by Pharma
Wed, 28 May 2014 13:07:31 +0100
Are FDA's New Revised "Rules" Too Limiting? Please take 2 minutes to answer a few short questions relating to the FDA's Revised Draft Guidance for Industry on Distributing Scientific and Medical Publications on Unapproved New Uses -- Recommended Practices; e.g., Limiting reprints to those that contain information from an "adequate and well-controlled clinical investigation." (Source: Pharma Marketing News)
Analysis of Pharma Promotional Spending in 2013
Wed, 28 May 2014 13:06:15 +0100
Professional Detailing, eDetailing, DTC Advertising, Professional Meetings, Journal Advertising (Source: Pharma Marketing News)
The Emerging Virtual Medical Conference
Wed, 28 May 2014 13:05:14 +0100
This article describes the changes occurring viz-a-viz major medical conferences and the impact this will have on the pharmaceutical industry, medical societies, healthcare professionals, and patients. (Source: Pharma Marketing News)
Pharmaguy's Social Media Compendium
Thu, 24 Apr 2014 14:31:12 +0100
A Comprehensive History & Guide to the Pharmaceutical Industry's Social Media Trials, Tribulations, and Triumphs Pharmaguy's Social Media Compendium is a catalog of articles, blog posts, podcasts, and surveys, all documenting the use of social media by the pharmaceutical industry from 2005 through 2013. It is updated frequently. (Source: Pharma Marketing News)
Pharma Finds Little to Like in Recent FDA Social Media Guidance
Thu, 24 Apr 2014 14:29:54 +0100
This article provides highlights from submissions by Novartis, Shire, and others. (Source: Pharma Marketing News)
The Sorry State of Pharma Mobile Health Apps
Thu, 24 Apr 2014 14:29:05 +0100
This articles summarizes some major points made by Carolyn Gauntlett, Senior Innovation Consultant with IMS Health, in her presentation "How to Make Sure You're Getting the Most Out of Your mHealth App Development" at the recent eyeforpharma Philadelphia 2014 Summit (Source: Pharma Marketing News)
Right & Wrong Ways for Pharma to Correct Misinformation on Wikipedia
Mon, 31 Mar 2014 11:21:23 +0100
This article discusses both the right and wrongs ways for pharma to edit Wikipedia articles about its products using real-life examples. (Source: Pharma Marketing News)
The Virtual Sales Rep
Mon, 31 Mar 2014 11:20:52 +0100
This article presents a Wockhardt USA case, which employed the vRep virtual sales rep platform. (Source: Pharma Marketing News)
Social Media, Latent Spokespersons & Native Advertising
Mon, 31 Mar 2014 11:20:49 +0100
This article focuses on a few of the issues, gray areas, and questions mentioned during the 'Green light or go slow' webcast and also in comments submitted to the FDA. (Source: Pharma Marketing News)
The Pharmaguy Social Media Timeline
Thu, 27 Feb 2014 15:06:12 +0100
Volume 2: June 14, 2011 through January 31, 2014 Since then there have been many noteworthy pharma social media events, trials, and tribulations that deserve to be added to the Timeline. Volume Two includes 23 new items/events (Source: Pharma Marketing News)
Pharma Brand Personality Traits
Thu, 27 Feb 2014 15:06:03 +0100
Imbuing Brands With Human Characteristics Can Boost Sales According to Lea Katsanis, PhD, Marketing Professor at Concordia University's John Molson School of Business, developing a strong brand personality is an important way that pharmaceutical marketers can increase brand loyalty, brand trust, and ultimately brand equity. (Source: Pharma Marketing News)
Do TV DTC Ads Overstate Rx Drug Risks?
Thu, 27 Feb 2014 15:05:10 +0100
FDA Poised to Tip Balance in Favor of Benefits FDA intends to look for evidence that the "major statement" of drug risks as currently implemented in DTC TV ads is often too long and "may result in reduced consumer comprehension, minimization of important risk information and, potentially, therapeutic noncompliance due to fear of side effects." (Source: Pharma Marketing News)
The Year 2013 in Images
Mon, 27 Jan 2014 14:15:20 +0100
Pharmaguy's Favorites from Pharma Marketing Blog Every year Pharmaguy reviews the images that appeared on Pharma Marketing Blog and picks his favorites. 2013 is no exception. (Source: Pharma Marketing News)
FDA Publishes First Piece of Long-Awaited Social Media Guidance
Mon, 27 Jan 2014 14:15:18 +0100
Focus is on Accountability A Public Affairs Specialist at FDA's Center for Drug Evaluation and Research (CDER) confirmed to several reporters that this guidance is actually PART of the long-awaited guidance that was promised after the November, 2009 public hearing and required by section 1121 of the Prescription Drug User Fee Act (PDUFA). (Source: Pharma Marketing News)
Leveraging Infographics and Search for Better Health Communications
Mon, 27 Jan 2014 14:14:02 +0100
This article discusses how Centric Infographics worked with the Foundation to create the infographic system at the center of this successful campaign. (Source: Pharma Marketing News)
Pharma Content Marketing Strategies
Mon, 27 Jan 2014 14:12:47 +0100
This article includes insights on content marketing from pharma experts including Thibaud Guymard, Digital Marketing Manager at MSD France. Guymard has broad experience with pharma content marketing, including roles as co-creator of the Digital Health Think Tank and as an Advertising Manager at Saatchi & Saatchi Health. Guymard also assisted in developing the Pharma Content Marketing Webinar organized by Kakushin Webinars. (Source: Pharma Marketing News)
Active Social Media Listening
Wed, 18 Dec 2013 14:16:31 +0100
This article summarizes a conversation with Trish Nettleship, Director, Social Media & Influence, UCB, Inc., about her company's approach to social media listening. (Source: Pharma Marketing News)
Measuring Physician Interaction with Pharma Brands
Wed, 18 Dec 2013 14:16:18 +0100
This article summarizes that discussion. (Source: Pharma Marketing News)
Evaluating Rx & OTC DTC TV Ads
Wed, 18 Dec 2013 14:15:22 +0100
This article is a summary of a study that evaluated claims in consumer-targeted television drug advertising against pharmacological evidence in order to determine the frequency of false or misleading claims made in these ads. (Source: Pharma Marketing News)
Pharmaguy's Social Media Compendium
Tue, 08 Oct 2013 15:17:34 +0100
A Comprehensive History & Guide to the Pharmaceutical Industry's Social Media Trials, Tribulations, and Triumphs Welcome to Pharmaguy's Social Media Compendium, which is a catalog of articles, blog posts, podcasts, and surveys, all documenting the use of social media by the pharmaceutical industry from 2005 through today. Through this compendium you are able to relive the fascinating history of the pharmaceutical industry's social media trials & tribulations and ultimate triumphs. (Source: Pharma Marketing News)
Pharma Marketing Ethics & Corporate Reputation Compendium
Tue, 08 Oct 2013 15:17:30 +0100
Bad, Devalued, Distrusted & Defensive Pharma Welcome to The Pharma Marketing Ethics & Corporate Reputation Compendium, which is a catalog of articles, blog posts, podcasts, and surveys about the pharmaceutical industry's marketing practices viz-a-viz ethics and its corporate reputation. (Source: Pharma Marketing News)
Pharma and Social Media - Comfy Bedfellows
Mon, 09 Sep 2013 14:28:43 +0100
This article reviews social media breakthroughs by Boehringer, AstraZeneca, & Janssen. Comfy, but not yet cozy! (Source: Pharma Marketing News)
Physicians Under Pharma's Influence
Mon, 09 Sep 2013 14:27:49 +0100
Are Physicians Powerless Pawns of Pharma Psychology? Ethicists identify six 'principles of influence' that are key to the drug industry’s routine marketing strategies, which rely on the illusion that the industry is a generous avuncular partner to physicians. (Source: Pharma Marketing News)
Mobile Apps Track Sunshine Payments
Mon, 09 Sep 2013 14:26:57 +0100
This article is a review of CMS's OpenPayments App for Physicians and Industry. (Source: Pharma Marketing News)
Redeemed "Sinners" as Pharma Spokespeople
Wed, 31 Jul 2013 13:25:12 +0100
Novo Nordisk's Faith-Based Marketing Part Novo's diabetes marketing strategy involves celebrities who usually do not register with 'hoity-toity' upper-income white folk. These include NASCAR racecar driver Charlie Kimball, southern belle celebrity chef Paula Deen, and recently ordained Pentecostal minister Joseph Ward Simmons, aka Rev. Run of the hip-hop group Run-D.M.C. 'Redeemed sinner' seems to be a pattern among Novo Nordisk's celebrity spokespeople. (Source: Pharma Marketing News)
Pharma's Digital Media Adoption Curve
Wed, 31 Jul 2013 13:24:56 +0100
The Timing is Right for Innovators to "Hook Up" with Big Pharma The Pharma Digital Media Adoption Curve illustrates how the drug industry is overcoming the regulatory hurdles to adopting emerging digital technology and especially social media. (Source: Pharma Marketing News)
The Comeback of CME without Pharma
Wed, 31 Jul 2013 13:24:25 +0100
More Physician Participants, More Revenue, But Less Pharma Support Although the pharmaceutical industry still contributes slightly over $1 billion to support healthcare professional continuing medical education (CME) via grants, advertising, and exhibits, total pharma support continues to decrease. (Source: Pharma Marketing News)
Toward Patient-Centric Marketing
Tue, 21 May 2013 11:53:40 +0100
This article summarizes two presentations made at the eyeforpharma Barcelona 2013 conference. (Source: Pharma Marketing News)
What Do Physicians Think About DTC, ePromotion, and Social Media?
Tue, 21 May 2013 11:53:36 +0100
This article reviews several recent industry surveys and one new survey proposed by the FDA. The review provides a glimpse into how physicians perceive direct-to-consumer (DTC) advertising, which physicians use social networking the most in their professional lives, and why physicians may be growing cool toward ePromotion even as pharma steps up it ePromotion spending. (Source: Pharma Marketing News)
Pharma C-Suite Social Media Dummies
Mon, 20 May 2013 19:10:39 +0100
This article attempts to answer that question with the help of Alexandra Fulford, an independent pharmaceutical industry strategy consultant who has worked with several pharmaceutical companies developing and running digital and social media training programs and workshops. (Source: Pharma Marketing News)
Mobile Medical App Guidance & Beyond!
Wed, 17 Apr 2013 19:51:51 +0100
This article is a review of an interview of Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition. It covers the prospects for FDA's final guidance on regulation of MMAs and other regulatory issues that the mobile health community and FDA will likely face after publication of the "final" guidelines. (Source: Pharma Marketing News)
Get Social, #GetFit and Get Healthy
Wed, 17 Apr 2013 19:51:46 +0100
How GE Healthcare Uses Social Media & Gaming to Promote and Motivate Healthy Lifestyles A conversation with Angel Gonzalez, Founder & CEO, Ideagoras, and Veronica Botet, Global Manager, Digital and Social Media, GE Healthcare. The discussion focuses on the #GetFit initiative, a worldwide competition and social media campaign designed to raise public awareness about cancer prevention. (Source: Pharma Marketing News)
Spending on Direct-to-Consumer Advertising Takes a Nosedive
Mon, 18 Mar 2013 12:55:46 +0100
This article reviews data that supports one cause for the decrease in DTC spending not often mentioned: the shift to developing drugs for small populations of patients (so-called "orphan" drugs) and complex biologics, which may also be targeted to small populations. (Source: Pharma Marketing News)
Help Doctors Educate Patients About Their Condition & Treatment
Mon, 18 Mar 2013 12:55:09 +0100
This article is a review of Vivacare's service as part of a pharmaceutical brand's digital marketing efforts. (Source: Pharma Marketing News)
Pharma is Overcoming Social Media Hurdles
Mon, 18 Mar 2013 12:54:30 +0100
This article summarizes the results of the online 'Rate Your Social Media Marketing Readiness' self-assessment tool/survey and compares results from two different time periods to determine if any progress has been made in overcoming the risks faced by pharma in using social media. (Source: Pharma Marketing News)
Reigning in the "Wild West" of Mobile Health Apps
Wed, 20 Feb 2013 14:30:10 +0100
Will It Be FDA Regulation or Self-Regulation or Both? As with Web sites in the early days, it is difficult today for users of mobile health apps to be assured that the apps are reliable, accurate, based on valid information, and adequately safeguard users' information. In many ways, we are living through another digital "wild west" without any sheriffs to protect us. And it appears that we do need protection. (Source: Pharma Marketing News)
Will Ethics Revive (Exhume?) the Drug Industry's Reputation?
Wed, 20 Feb 2013 14:30:02 +0100
This article summarizes her ideas and presents opinions of several naysayers. (Source: Pharma Marketing News)
Self-Regulation as a Collective Blocking Strategy
Wed, 20 Feb 2013 14:28:49 +0100
PhRMA's DTC Guiding Principles Taken to Task Has the drug industry systematically violated PhRMA's DTC Principles? Is pharma self-regulation a deception meant to deflect criticism and block new FDA regulations? The answer is "yes," according to a study recently published in the Journal of Health Politics, Policy and Law. The study authors provide convincing evidence, which is summarized in this article. (Source: Pharma Marketing News)
Bad, Devalued, Distrusted & Defensive Pharma
Thu, 31 Jan 2013 15:47:11 +0100
This article, however, tells the Tale of Two Books: Bad Pharma, a 430-page book by Ben Goldacre, a British physician, whose previous book, Bad Science, was a best seller in the "non-fiction" realm and the much smaller 123-page book Devalued and Distrusted by John L. LaMattina, former president of research and develop at Pfizer. (Source: Pharma Marketing News)
Pharmaguy's Pharma Predictions
Thu, 31 Jan 2013 15:46:53 +0100
Looking at 2013 and Beyond! To usher in the New Year, it's traditional for pundits like Pharmaguy (aka John Mack, Publisher of Pharma Marketing News) to go out on a limb and make a few pharma industry predictions for the year. (Source: Pharma Marketing News)
The Year 2012 in Images
Thu, 27 Dec 2012 13:12:04 +0100
A Select Review of Pharma Industry News & Trends "These are my favorite images and stories published on Pharma Marketing Blog during 2012. I think it's a good summary of some of the major trends in the industry. Feel free to view and download the Slideshare version too." -- Pharmaguy, a pharma "aficionado" (Source: Pharma Marketing News)
The Role of Social Media in Managing Chronic Diseases
Thu, 27 Dec 2012 13:11:53 +0100
In a blog post titled "Open letter to NPR about Diabetes Social Media piece," Kerri Morrone Sparling of Six Until Me, attempted to refute a claim made by Jason Bronner, a doctor at the University of California San Diego Medical Center, who said "There's no proof in diabetes that social networking is helpful." Sparling says "initial evidence suggests that the benefits of social media to people living with chronic illness are real, even though large scale studies have not shown precisely who benefits and how much." OK. What we have here is a failure to communicate. On the one hand, there's the physician who's looking for "evidence" that diabetes is being managed. That involves numbers such as HbA1c (a lab test that shows the average level of blood sugar over the previous three months; It...
What's at Stake in the Off-Label Debate
Thu, 27 Dec 2012 13:11:01 +0100
Freedom of speech may be the legal issue, but reducing drug trial costs is the business goal The FDA defines off-label Rx drug use as, "use for indication, dosage form, dose regimen, population or other use parameter not mentioned in the approved labeling." In the US, it is legal for doctors to write off-label prescriptions. Up until now, it has not been generally legal for pharmaceutical companies to promote any drugs they manufacture for off-label use. The most recent case was a 2-to-1 split decision by the 2nd U.S. Circuit Court of Appeals in New York that threw out the conviction of a sales representative for promoting off-label use of a prescription drug. There are enough legal issues in this case to keep a boatload of constitutional and pharma lawyers busy for years. But let's lo...
Google's New Drug Search Result Format
Thu, 27 Dec 2012 13:09:59 +0100
A "Knowledge Graph" that doesn't include pharma! "We get a lot of queries for medicine on Google," said Aaron Brown, Senior Product Manager for Search at Google in a blog post. "So to make it quick and easy for you to learn about medications, we'll start showing key facts -- side effects, related medications, links to in-depth resources, and more -- right on the search results page. This data comes from the U.S. FDA, the National Library of Medicine, and the Department of Veterans Affairs, among others. It's part of the Knowledge Graph -- our project to map out billions of real-world things, from famous artists to roller coasters to planets (and now medications)." It's currently available to English speakers in the U.S. But no information in the box comes directly from pharmaceutical com...
How is the iPad an Effective Delivery Platform for Medical Sales Professionals?
Wed, 21 Nov 2012 16:42:14 +0100
This article presents some key findings of an MD Snapshot™ study performed by MD Mindset that benchmarked and tracked the impact of iPad use on sales rep messaging effectiveness and delivery. (Source: Pharma Marketing News)
Mobile Optimization Offers Better ROI Than Mobile Apps
Wed, 21 Nov 2012 16:40:27 +0100
This article reviews PEW's health app data and presents data and best practices from Google that supports this this conclusion. (Source: Pharma Marketing News)
The Future of Pharma Marketing is Mobile, Unless…
Thu, 15 Nov 2012 16:42:01 +0100
…FDA's "Enforcement Discretion" Remains Unclear You don't need a crystal ball to know that the future of media is mobile. While pharmaceutical companies may not yet be advertising on mobile devices as they do on TV, websites, and magazines, they are developing health apps that run on Droid smartphones, iPhones and iPads. Many observers feel that the pharma industry lags behind other industries as far as having a mobile strategy is concerned. One of the factors that may be holding back pharma in its pursuit of a mobile strategy is the loomimg sepecter of FDA regulations. (Source: Pharma Marketing News)
Sanofi US Diabetes Team Wins 3rd Annual Pharmaguy Social Media Pioneer Award
Tue, 23 Oct 2012 13:16:29 +0100
PharmaGuy (aka John Mack) presented the coveted bright yellow Hawaiian shirt/Pharmaguy Social Media Pioneer Award to Dennis Urbaniak, VP, Joan Mikardos, Senior Director, and Laura Kolodjeski, Senior Manager, Patient Solutions, at Sanofi US Diabetes. The award was made at the 6th Annual Digital Pharma East conference in Philadelphia on October 17, 2012. Accepting the award on behalf of the winners -- who could not make it in person -- was Wendy Blackburn of Intouch Solutions. (Source: Pharma Marketing News)
The iPad in the Doctor's Office
Tue, 23 Oct 2012 13:16:10 +0100
This article reviews Appature Nexus, a Marketing Cloud software platform that drives sales growth through an integrated marketing database, campaign management tool and reporting/analytics engine. (Source: Pharma Marketing News)
Is Online Pharma Advertising ROI Scalable?
Tue, 23 Oct 2012 13:15:37 +0100
Do the Benefits Outweigh the Risks? At the recent 6th Annual Digital Pharma East conference in Philadelphia, Bill Drummy, CEO of HeartBeat Ideas, argued that "With digital you can get way more bang for your buck, so you HAVE to think of the digital channel." Drummy's message was simple: the ROI of online promotion is an order of magnitude greater than the "typical" 2:1 ROI for non-digital channel promotion. This may be true of small budget campiagns, but is it scaleable to the point where digital promotion gives you a significant bump in sales? (Source: Pharma Marketing News)
Making Sense of Multichannel Marketing
Tue, 23 Oct 2012 13:14:37 +0100
This article summarizes the discussion lead by Starnes during a recent MultiChannel Webinar hosted by eyeforpharma, which is also hosting the 2nd Annual Multichannel and Mobile Strategy conference November 29-30, 2012, in London. Also speaking at the webinar was Tim White, Head of Digital Commercialization - Europe for Novartis, Benedikt Hoffmann, Head of eBusiness, Janssen, and Morten Kamp Jorgensen, Director, Corporate Brand & Reputation, at Vestas, a company that specializes in wind power solutions. (Source: Pharma Marketing News)
Who Owns Your Social Media?
Mon, 10 Sep 2012 17:48:50 +0100
Health Is Social, But Privately Owned and Operated Twitter's new rules change the playing field for third party developers, establish caps on number of users, and shift guidelines to requirements across four categories of businesses. Will the new rules ruin the spirit of social media and are they bad for healthcare? (Source: Pharma Marketing News)
The iPad in the Doctor's Office
Mon, 10 Sep 2012 17:48:17 +0100
This article reviews the latest results of that study. (Source: Pharma Marketing News)
Adherence: Do We Really Need an App for That?
Mon, 10 Sep 2012 17:47:42 +0100
Do the Benefits Outweigh the Risks? Lots of patients -- even patients taking life-saving medication -- are not as "adherent" as they should be, which means that the treatment does not work as advertised and drug companies lose money. There have been many attempts by the drug industry to improve medication adherence, but it has been a tough challenge. The industry, however, has not given up. The new battleground for combating non-adherence is the mobile smartphone and the smartphone app is the weapon of choice. Are the benefits worth the risk? (Source: Pharma Marketing News)
Pharma Paid Celebrity Best Practices
Mon, 10 Sep 2012 17:46:37 +0100
Should Pharma Disclose Payments to Celebrity Spokespeople? Pharma marketers in the U.S. sometimes use celebrities as spokespeople for their branded drugs or for non-branded campaigns. Such celebrities include TV personalities, athletes, movie stars and others who have thousands or millions of fans, Twitter followers, etc. Should Pharma Disclose Payments to Celebrity Spokespeople? This is just one of the issues explored in a recent survey of Pharma Marketing News readers. (Source: Pharma Marketing News)
Gamification: Now and Then
Thu, 26 Jul 2012 14:19:47 +0100
There's a lot of brouhaha these days in pharma circles about 'gamification' as if it were the newest thing since sliced bread. These days, however, it may be easier for a pharma company to create a real-life museum educational gaming experience than a virtual world game on Facebook. Way back in 1984, gamification was much simpler. (Source: Pharma Marketing News)
Multichannel Marketing & Medical Reprints
Thu, 26 Jul 2012 14:19:23 +0100
Putting Science on iPads, Apps, and HCP Websites The distribution of medical reprints to healthcare professionals (HCPs) by sales reps is not only a logistical problem but a channel problem as well. Reprints Desk helps pharmaceutical companies to deploy copyrighted e-prints and other marketing materials via iPads and other tablets, or via their own apps and websites in a controlled manner as part of a multichannel marketing campaign. (Source: Pharma Marketing News)
Multichannel Marketing: Easy to Brag About, but Difficult to Do
Thu, 26 Jul 2012 14:19:04 +0100
Multichannel pharma marketing is conceptually relatively simple to understand, but incredibly difficult in practice, says Len Starnes, former Head of Digital Marketing & Sales, General Medicine at Bayer Schering Pharma. That said, multichannel is not a transient phenomenon, it's here to stay. Starnes hosted a survey on LinkedIn to answer the question: When will pharma marketing become de facto multichannel marketing in future? (Source: Pharma Marketing News)
Crowd Sourced Creative Commons Drug Information
Thu, 26 Jul 2012 14:18:18 +0100
This article summarizes the pros and cons of pharmaceutical companies editing Wikipedia articles to correct "misinformation" about their drugs. (Source: Pharma Marketing News)
Exploring the 2.0 Doctor-Patient Relationship
Thu, 31 May 2012 19:50:35 +0100
This article summarizes the survey results. (Source: Pharma Marketing News)
Pfizer Throws In the Lipitor Marketing Towel
Thu, 31 May 2012 19:50:19 +0100
Crestor's Opportunistic Cheap Shot Despite Pfizer's heroic and unprecedented effort to maintain Lipitor's market share after expiry last November and after spending more than $87 million promoting the medicine, the world's biggest drug company is quietly giving up on its once-great cash cow for good because more generic versions will soon be going on sale. Meanwhile, AstraZeneca promoted Crestor on its corporate blog. It's unusual for a pharmaceutical company to mention a product by brand name on its corporate blog. (Source: Pharma Marketing News)
Pharma Responds to FDA's Draft DTC Guidelines
Thu, 31 May 2012 19:49:30 +0100
This article reviews the comments submitted by PhRMA, Sanofi, and Shire. Comments from other pharma companies addressed similar issues to the ones reviewed here. (Source: Pharma Marketing News)
The Evolving Pharma-Physician Relationship
Thu, 31 May 2012 19:49:15 +0100
New Power Players & New Technology Force Changes Dorothy Wetzel, the Founding Partner and Chief Extrovert at extrovertic, offers her top 3 takeaways about what pharma marketers should be doing differently in the future based on presentations made at the PharmaMarketing Summit 2012 in Chicago. In addition, John Mack summarized the presentation made by Dr. Frank Spinelli, a physician currently in private practice and formerly the Clinical Director of HIV Services at New York's Cabrini Medical Center. (Source: Pharma Marketing News)
Do Drug Copay Coupons Drive Up Healthcare Costs?
Mon, 19 Mar 2012 14:51:13 +0100
Union Health Plans Say "Yes" Coupons for drug co-payments are illegal and drive up long-term health-care costs for all, a consumer group and four trade-union health-insurance plans said in announcing lawsuits against eight pharmaceutical companies. The lawsuits claim that although coupons reduce the consumer's out-of-pocket cost, the health insurer still pays the previously negotiated price to the drug company. With no savings from generics, health plans will need to charge patients more to keep up with rising costs, the lawsuits say. (Source: Pharma Marketing News)
HealthPrize Teams Up with RealAge to Improve Adherence
Mon, 19 Mar 2012 14:50:50 +0100
This article summarizes the results of a six-month asthma and chronic obstructive pulmonary disease (COPD) pilot study in which HealthPrize partnered with RealAge to test patient engagement with the HealthPrize online and mobile platform. (Source: Pharma Marketing News)
US Drug Shortage & Supply Chain Crisis
Mon, 19 Mar 2012 14:50:21 +0100
Pharma's Missed Opportunity to Support Patients via Social Media Although many pharmaceutical companies actively use Twitter and other social media tools to push out positive news about their companies and products, very few use these tools for systematic support of patients who depend upon their drugs, which may be short supply. (Source: Pharma Marketing News)
Focus on Drug Safety Communication & TV DTC Advertising
Mon, 19 Mar 2012 14:49:15 +0100
This article reviews two recently published and important guidances from the FDA that concern the dissemination of drug information to consumers. (Source: Pharma Marketing News)
The Coming Pharma Digital Depression
Wed, 22 Feb 2012 18:43:39 +0100
P&G Discovers It's "Free" to Advertise on Facebook! Pharma Next? A 'recession' in pharma marketing is likely considering the well-known 'patent cliff' that's currently in progress; ie, blockbuster drugs with a combined $170 billion in annual sales will go off-patent by 2015. That means even less mass media advertising and more digital advertising. But 'more digital advertising' does not mean that much more money will be spent in the digital arena. That's because of social media, where it's virtually free to advertise! (Source: Pharma Marketing News)
Big Bad Pharma
Wed, 22 Feb 2012 18:43:03 +0100
This article reviews the confluence of several trends that are putting the industry on the defensive with data from several surveys and studies that put these issues into context of the age of social media amplification of news sound bites and instant online collaboration. (Source: Pharma Marketing News)
Some Unregulated Physician Smartphone Apps May Be Buggy
Wed, 22 Feb 2012 18:42:43 +0100
Especially "Calculator" Apps Like These...Practically every pharmaceutical company has one or more apps. The ones I am interested in are apps designed to help doctors in their diagnosis of patients. Big among these are the "calculator" apps, which calculate things such as glomerular filtration rate (GFR), Medication Adherence Rating Scale (MARS), Delayed Graft Function (DGF) Risk, creatinine clearance, dosing algorithms, Body Mass Index (BMI), and, my favorite, Psoriasis Area and Severity Index (PASI). At least one of these apps has been recalled due to a software bug. But recalling does not mean it's not still being used by physicians. (Source: Pharma Marketing News)
Mobile Regulatory Fears
Wed, 22 Feb 2012 18:41:51 +0100
PhRMA Raises an Alarm In a blog post provocatively titled 'An App for That, But For How Much Longer?', PhRMA's Kate Connors agreed with a Washington Times op-ed piece that suggested the FDA will soon require apps such as medication prescription renewal reminders and blood glucose level tracking functions to be regulated as medical devices. The op-ed author, Joel White, executive director of the Health IT Now Coalition, suggests that this effort would lead to increased costs as well as constraints on user access to these apps, which 'may cause developers to move on to other, less burdensome endeavors.' 'In the end, this could hinder the way that patients can actively improve their own care,' said Conners. Is this fear warranted? Are there apps that SHOULD be regulated by the FDA? Read this...
Is There a Cure for Mediocre Pharma Mobile Apps?
Thu, 26 Jan 2012 15:44:34 +0100
Listen Up, New Marketing Grads! Mobile is the new 'shiny thing' of interest to pharmaceutical marketers. However, most pharma mobile apps that I have seen are pretty mundane as far as marketing/advertising is concerned. What's it going to take to make these apps more interesting and useful? (Source: Pharma Marketing News)
Novo Nordisk Defends Choice of Paula Deen as Diabetes Spokesperson
Thu, 26 Jan 2012 15:44:09 +0100
Unless you are living under a rock on the Moon, you've probably heard that Novo Nordisk has teamed up with celebrity Southern-style chef Paula Deen as a paid spokesperson. Ambre Morley, Associate Director, Product Communications, Novo Nordisk, answers questions about why her company teamed up with Deen as a diabetes spokesperson. (Source: Pharma Marketing News)
FDA Social Media Guidelines May Be Moot
Thu, 26 Jan 2012 15:43:45 +0100
This article presents the relevant case information. (Source: Pharma Marketing News)
FDA Guidance on Responding to Unsolicited Requests for Off-Label Information
Thu, 26 Jan 2012 15:42:44 +0100
This article takes a closer look at how the off-label guidelines apply to social media such as Youtube, Blogs, and Twitter. (Source: Pharma Marketing News)
Proposed Rules for Physician Payment Sunshine Act
Wed, 21 Dec 2011 12:25:33 +0100
This article reviews the strategic implications of the Sunshine Act and also presents highlights of the draft regulations rule released by the Centers for Medicare and Medicaid Services on December 15, 2011. (Source: Pharma Marketing News)
Checking Under the Hood of Pharma Mobile Apps
Wed, 21 Dec 2011 12:25:28 +0100
Let's look 'under the hoods' of two pharma-sponsored mobile apps and compare disclaimers. We'll compare Janssen's PASI calculator, which has an update disclaimer, with the new AFib Educator 2.0 app developed by Sanofi-Aventis. (Source: Pharma Marketing News)
Politics Vs. Science in the Plan B Decision
Wed, 21 Dec 2011 12:25:05 +0100
HHS Secretary Sebelius focused on the fact that Teva's study did not contain data for all ages for which this product would be available for use. According to Tina Raine-Bennett, MD, MPH, of the Women's Health Research Institute at Kaiser Permanente Northern California, a principal investigator of the University of California-San Francisco study, it is unreasonable and virtually impossible to study the use of emergency contraception in 11- and 12-year-olds, because only a small fraction of them will have had sex by that age. (Source: Pharma Marketing News)
Certain Physician-Drug Industry Relationships Have Declined Dramatically
Wed, 21 Dec 2011 12:24:33 +0100
The authors of a physician survey published in the of Archives of Internal Medicine conclude 'given that 83.8% of physicians have PIRs, it is clear that industry still has substantial financial links with the nation's physicians. These findings support the ongoing need for a national system of disclosure of PIRs [Physician-Drug Industry Relationships].' Such a system is part of the Physician Sunshine Law, which is scheduled to go into effect in 2012 with public disclosure of payments scheduled to begin September, 2013. (Source: Pharma Marketing News)
Are Pharma Sales Reps Service Employees?
Thu, 01 Dec 2011 17:30:18 +0100
The Supreme Court has agreed to decide whether drug companies have to pay their sales representatives for working overtime hours. The question before the court in case CHRISTOPHER V. SMITHKLINE BEECHAM CORP is whether or not pharmaceutical sales representatives are exempt from overtime pay under the "outside sales" exemption of the Fair Labor Standards Act of 1938. If the Supreme Court rules that pharma sales reps are NOT exempt, some sales reps worry that they will become "service" employees similar to UPS/Fed Ex delivery people. (Source: Pharma Marketing News)
Deconstructing Pitts' Guiding Principles for Pharma Social Media
Thu, 01 Dec 2011 17:29:19 +0100
This article takes a closer, critical look at "Pitts' Principles" and discusses how successful the pharma industry has been at following these principles to date. (Source: Pharma Marketing News)
The Digital Life of Doctors
Thu, 01 Dec 2011 17:27:51 +0100
While primary care physicians in general are frequent users of the Internet, oncologists see online sources of information as more important than PCPs and therefore may need less personal contact to learn about products. That was just one of the results from the 2011 Digital Life survey of 1,454 physicians summarized is this article. (Source: Pharma Marketing News)
Limiting Bias in Commercially Supported CME
Thu, 01 Dec 2011 17:26:56 +0100
Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article. (Source: Pharma Marketing News)
The Changing Pharma eDetailing Landscape
Thu, 01 Dec 2011 17:24:22 +0100
A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets. (Source: Pharma Marketing News)
Pfizer Battles to Protect Lipitor Cash Cow
Thu, 01 Dec 2011 17:23:49 +0100
Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand. (Source: Pharma Marketing News)
Are Pharma Reps Important to Docs or Not?
Thu, 10 Nov 2011 19:31:49 +0100
One survey says yes, pharma reps are important to physicians, another says not so much. Who are we to believe? (Source: Pharma Marketing News)
Maximizing Stakeholder Effectiveness
Thu, 10 Nov 2011 19:31:47 +0100
A summary of the highly anticipated 2011 results of Kantar Health's annual Stakeholder Effectiveness survey, which revealed that over two-thirds of respondents from leading companies in the pharmaceutical sector think that customer retention is a key performance measure. (Source: Pharma Marketing News)
Pharma Turns Up Heat to Unchill Off-Label "Free Speech"
Thu, 10 Nov 2011 19:31:16 +0100
The drug industry brings legal heat to the issue of off-label drug promotion. (Source: Pharma Marketing News)
Pharma YouTube Patient Videos Lack Transparency
Thu, 10 Nov 2011 19:30:46 +0100
Pharma social networking sites like Facebook and YouTube may lack patient-centered information and can also be sources of misleading information that could potentially do more harm than good. (Source: Pharma Marketing News)
Pfizer's Chapstick Slapstick Facebook Fiasco
Thu, 10 Nov 2011 19:30:02 +0100
If pharma marketers are going to be successful engaging consumers (mostly women) via social media, then they need to be more sensitive about how they portray women in ads and very savvy about how they handle comments (if they allow comments). (Source: Pharma Marketing News)
Johnson & Johnson's ennTV
Thu, 10 Nov 2011 19:29:17 +0100
A conversation with Michael Heinley, Corporate Vice President, Leadership and Employee Communication, and Bill Price, Vice President, Media Relations, Johnson & Johnson, about the company's Employee News Network ("ennTV"), a new video news magazine produced for J&J employees worldwide. (Source: Pharma Marketing News)
Everything You Need to Know About Mobile Platforms
Thu, 27 Oct 2011 18:57:47 +0100
If you're thinking of developing a mobile application (app) for patients or physicians, you need to consider the myriad platforms -- hardware plus software combinations -- that are out there and determine which platform is best suited for your intended audience. Your choice of platform will impact your app's performance, maintenance, and security, which in turn will make or break the success of the app. (Source: Pharma Marketing News)
Antidepressants: Top Advertised & 3rd Most Commonly Used Rx Drug
Thu, 27 Oct 2011 18:57:41 +0100
According to a recent CDC Data Brief, antidepressants were the third most common prescription drug taken by Americans of all ages in 2005–2008 and the most frequently used by persons aged 18–44 years. From 1988–1994 through 2005–2008, the rate of antidepressant use in the United States among all ages increased nearly 400%. Perhaps not so coincidentally, antidepressants are among the TOP advertised Rx category in 2010, according to the recent AdAge analysis. (Source: Pharma Marketing News)
Without Free Gifts from Pharma to Docs, Would Research be Useless?
Thu, 27 Oct 2011 18:56:22 +0100
In a recent blog post, PhRMA said 'Without Promotion Research will be Useless.' To support its case, PhRMA cited 'an interesting opinion editorial' in the latest edition of the Annals of Emergency Medicine. In the op-ed, Emory University economist Paul Rubin, Ph.D. expressed concern that ACEP policy regarding Gifts to Emergency Physicians from Industry 'could have the unfortunate effect of limiting the exchange of critical information between medicine makers and physicians about the benefits and risks of new medicines, how to use them properly and how best to diagnose the right candidates for particular treatments.' (Source: Pharma Marketing News)
Is There an Upward Career Path for Pharma Social Media Pioneers?
Thu, 27 Oct 2011 18:54:50 +0100
Are we witnessing an exodus of social media "pioneers" from pharma similar to the exodus of interactive pioneers back at the turn of the century? That last exodus presaged the infamous "dotcom" bust. Perhaps the current exodus presages a similar setback for the social media industry. (Source: Pharma Marketing News)
Double Dip in DTC Ad Spend!
Thu, 27 Oct 2011 18:54:13 +0100
Direct-to-Consumer (DTC) pharmaceutical advertising spending suffered a 'double dip' recession between 2007 and 2010, according to data presented in the AdAge Insights Whitepaper "Pharmaceutical Marketing: Targeting Consumers & Connecting Online." Spending dipped 14% from a high of $5.4 billion in 2006 to $4.7 billion in 2008 and dipped again 9% in 2010 compared to 2009, which saw a modest 2.4% increase over 2008. Meanwhile, Internet display ad spending by top pharma advertisers decreased 33% in 2010 compared to 2009. (Source: Pharma Marketing News)
How to Score With Women (as a Marketer) via Social Media
Thu, 27 Oct 2011 18:53:43 +0100
A conversation with Casey Quinlan, 'Mighty Mouth' at Mighty Casey Media LLC, Zoe Dunn, Principal, Hale Advisors, Richard Meyer, Principal Consultant, Online Strategic Solutions, Jerry Hall, Digital Media Executive, Advisor to Pearescope, about engaging and marketing to women online, especially via social media, which some new media marketers claim is 'all about women.' (Source: Pharma Marketing News)
Physician Participation in Peer-to-Peer Social Media Sites
Wed, 12 Oct 2011 17:52:39 +0100
This article summaries research data exploring why physicians interested in using online peer-to-peer social communities outnumber by 2 to 1 physicians who are actually using them. Includes suggestions for what these communities must do in order to provide more value to physicians. (Source: Pharma Marketing News)
PhRMA Masters the Art of "Proofiness!"
Wed, 12 Oct 2011 17:52:33 +0100
In a recent video titled 'What Gets PhRMA's Chairman Up Every Morning?', Chris Viehbacher, CEO of Sanofi, cited an impressive Potemkin number related to life expectancy and the pharma industry. (Source: Pharma Marketing News)
The Big C in the Big Apple
Wed, 12 Oct 2011 17:51:41 +0100
HepC.tv is featuring the video 'Man-on-the-Street: New Yorkers' Reactions to the Big Yellow C.' Is it effective? How do we know? (Source: Pharma Marketing News)
In Memory of Steve Jobs Will Novartis Sales Reps Really Embrace iPads?
Wed, 12 Oct 2011 17:51:06 +0100
David Epstein, head of Novartis Pharmaceuticals, said eighty percent of his company's sales reps will give up their PCs for iPads in 2012. Will they do it? (Source: Pharma Marketing News)
The Pozen Digital Advisory Board
Wed, 12 Oct 2011 17:50:28 +0100
A conversation with Elizabeth A. Cermak, EVP, and Chief Commercial Officerat Pozen, Raj Amin, CEO and Co-Founder of HealthiNation, and Bonin Bough, Senior Global Director of Digital and Social Media, PepsiCo, about the who, what, why behind the Pozen Digital Advisory Board, an esteemed group of digital thought-leaders both in and outside of healthcare. (Source: Pharma Marketing News)
Boehringer vs Facebook Social Media Socialism
Thu, 22 Sep 2011 20:58:39 +0100
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity. (Source: Pharma Marketing News)
Pharma's Physician Bailout
Thu, 22 Sep 2011 20:58:36 +0100
The pharmaceutical industry has been very generous in making payments to physicians. Last year (2010), for example, a mere dozen pharmaceutical companies paid $760 million to physicians and other health care providers for consulting, speaking, research and expenses. On average, how much do you think that comes to for every physician in the U.S.? (Source: Pharma Marketing News)
Orphan Drugs Now "Where the Money Is," Says Willie Sutton's Ghost
Thu, 22 Sep 2011 20:58:03 +0100
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer. (Source: Pharma Marketing News)
New Big Pharma Economies of Scale
Thu, 22 Sep 2011 20:57:32 +0100
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing? (Source: Pharma Marketing News)
British Pharma Digital Update
Wed, 24 Aug 2011 14:30:20 +0100
This article reports the results of an informal Weber Shandwick survey regarding social media guidelines recently published by the British pharmaceutical industry regulators. Includes advice on how to innovate online without waiting for more specific guidelines from regulators. (Source: Pharma Marketing News)
Four Useful Lessons Pharma Can Learn from the Pfizer Facebook Hack
Tue, 23 Aug 2011 13:08:59 +0100
Pfizer's US corporate Facebook page was "hacked" by some "Kiddies." What should the industry learn from this experience? (Source: Pharma Marketing News)
Pharma Facebook Pages Being Phased Out: A Good Run While It Lasted!
Tue, 23 Aug 2011 13:06:05 +0100
No doubt you've heard that as of August 15, 2011, Facebook opened up comments on ALL pharma pages with some exceptions. That means that the pharmaceutical industry will no longer be able to shut off comments on their Facebook pages. (Source: Pharma Marketing News)
PR & Interactive Agencies Vie for Pharma Social Media Campaign Crumbs
Tue, 23 Aug 2011 13:06:01 +0100
Should a PR firm or an interactive marketing agency be in charge of pharma social media campaigns? (Source: Pharma Marketing News)
Vast Majority of Drug Ads in Leading Medical Journals Don't Pass MDs' Sniff Test!
Tue, 23 Aug 2011 13:04:02 +0100
A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements (83 full unique advertisements) in biomedical journals found that only 18 percent (15) were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death. (Source: Pharma Marketing News)
The Digital Health Coalition
Thu, 21 Jul 2011 17:12:16 +0100
Solving Real Problems -- Mission Possible? A conversation with Mark Bard, founder of the Digital Health Coalition, regarding the mission of the Coalition and what companies and individuals are involved. (Source: Pharma Marketing News)
Adobe Connect for eDetailing
Thu, 21 Jul 2011 17:12:16 +0100
This article focuses on Adobe Connect for eDetailing, a specific collaboration between Adobe and ConnectSolutions, a leading provider of private cloud deployments of web conferencing and collaboration solutions. (Source: Pharma Marketing News)
SURVEY: Rules for Pharma Engagement in Patient & Physician Social Networks
Thu, 21 Jul 2011 16:49:44 +0100
How Should Pharma Engage in Patient/Physician Social Networks? Should owners and operators of online discussion sites -- whether they be independent corporations such as Sermo, or hospitals, other healthcare organizations, and even pharmaceutical companies (someday) -- publish SOCIAL MEDIA POLICIES that comply with as-yet-to-be-determined "fair social media practice principles?" (Source: Pharma Marketing News)
FDA is Monitoring This Blog and Perhaps You Too!
Thu, 21 Jul 2011 16:48:08 +0100
he FDA may be using sophisticated monitoring tools to mine the Internet -- including "any website/blog/microblog, social media or online publication" -- that "mentions ... the FDA and special topics of interest to the FDA." The FDA does not say why it needs to monitor sites that merely "mention" the FDA nor what "special topics" it is interested in. Could it be the agency is getting nervous about all the criticism it is getting for not being very productive in issuing social media guidance? (Source: Pharma Marketing News)
Pfizer, Show Us Your Social Media "Playbook"
Thu, 21 Jul 2011 16:47:32 +0100
At a recent conference, Ray Kerins, Vice President of Worldwide Communications at Pfizer, mentioned Pfizer's "groundbreaking internal Social Media Playbook." When asked outright if there is anything in the playbook that can be made public or if a copy would be made available for review, Kerins said: "NO!" Why can't we see it? (Source: Pharma Marketing News)
Tracking Public Health Trends
Thu, 21 Jul 2011 16:46:44 +0100
Twitter vs Google vs Your Nose Researchers at the Johns Hopkins Center for Language and Speech Processing have analyzed 2 billion public tweets posted between May 2009 and October 2010 to learn if it is possible to use Twitter to track important public health trends. (Source: Pharma Marketing News)
Citizen Petition Likely to Delay FDA Social Media Guidance
Thu, 21 Jul 2011 16:46:09 +0100
Six major pharmaceutical companies filed a "citizen petition" with the FDA, urging the agency to "establish comprehensive, clear and binding regulations to guide the industry" in communicating off-label drug information to physicians and payers. This petition is likely to delay social media guidance from the FDA. (Source: Pharma Marketing News)
The Pharmaguy Social Media Timeline
Thu, 09 Jun 2011 10:12:06 +0100
A Unique Record of Social Media Events Impacting the Pharmaceutical Industry The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline™ now, at a time when the industry already has set precedents in every social media application. (Source: Pharma Marketing News)
First FDA Social Media Guidance to Address Responding to "Unsolicited Requests" for Off-label Information
Wed, 08 Jun 2011 12:41:43 +0100
Why did the FDA put "Responding to Unsolicited Requests" at the TOP of its list of "issues related to Internet/social media promotion of FDA-regulated medical products" for which it promises to issue guidance in 2011? Where did that issue arise? It wasn't mentioned in the Federal Register and there was only one mention of "unsolicited" in presentations made at the November, 2009 public hearing. That presentation put forward a social media off-label user-generated content scenario for which the FDA might issue guidance in 2011. (Source: Pharma Marketing News)
The Pharmaguy Social Media Timeline&trade
Wed, 08 Jun 2011 12:40:33 +0100
A Unique Record of Social Media Events Impacting the Pharmaceutical Industry The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline™ now, at a time when the industry already has set precedents in every social media application. (Source: Pharma Marketing News)
FDA Drops "Social Media" from Its 2011 Guidance Agenda
Wed, 08 Jun 2011 12:40:05 +0100
Missing from the "Guidance Agenda: New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2011" is "Promotion of Prescription Drug Products Using Social Media Tools", which WAS on the 2010 Agenda. What's up with that? (Source: Pharma Marketing News)
FDA, DOJ, & Google: Conspiracy Theory, Part 2
Wed, 08 Jun 2011 12:39:22 +0100
FDA was involved in the criminal investigation of Google by the Department of Justice (DOJ). In light of that, was FDA's infamous 14 warning letters sent to major pharma companies regarding violative search engine ads a "shot across Googles bow," intended to force Google to halt its acceptance of ads from "illegal" online pharmacies? (Source: Pharma Marketing News)
New Facebook Policy "Kind of Hurts" Pharma Marketers
Wed, 08 Jun 2011 12:37:37 +0100
An official Facebook statement says: "In an effort to encourage conversations between brands and people, we recently made some changes to our policies that affect some official pharmaceutical pages directed at building communities. This change does not affect pages for prescription drugs. We think these changes will help encourage an authentic dialogue on pages." (Source: Pharma Marketing News)
Finding the Consumer Within the Patient
Wed, 08 Jun 2011 12:36:46 +0100
Insights Into How Healthcare Decisions are Made A conversation with Grace Soyao, Founder & Chief Strategy Officer of Self Care Catalysts Inc., a health research and strategy company, about her company's unique and proprietary processes and tools specifically designed using health psychology to understand how today's patients/healthcare consumers make healthcare decisions. (Source: Pharma Marketing News)
Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?
Wed, 18 May 2011 17:57:15 +0100
This article discusses the regulatory and other issues associated with pharma developed or sponsored health apps. (Source: Pharma Marketing News)
Physicians Are Concerned That Pharma Supported CME is Biased, But ...
Wed, 18 May 2011 17:56:42 +0100
Commercial funding of continuing medical education (CME) and the potential for bias appear to concern many physicians, yet only a TINY MINORITY (7%) are willing to pay registration fees to eliminate or offset commercial funding sources, according to a report in the May 9 issue of Archives of Internal Medicine. Find more results of the survey here. (Source: Pharma Marketing News)
eDetailing Technology & Birth of "Sales Cyborg"
Wed, 18 May 2011 17:56:06 +0100
"Big pharmaceutical companies have found replacements for the army of sales representatives they've laid off in recent years: digital sales tools that seek to sell doctors on drugs without the intrusion of an office visit," says the WSJ. Some sales reps may morph into what could be called "sales cyborgs" who engage in remote live human conversations with physicians aided by technology. (Source: Pharma Marketing News)
FDA's BadAd Program Lacks Credible Evidence
Wed, 18 May 2011 17:54:49 +0100
A recent FDA notice of violation letter resulting from its BadAd program reads like charges made by a prosecutor at a criminal trial except there's no trial. And there's no credible evidence such as violative detail aids, brochures, etc! Read more, including the letter here. (Source: Pharma Marketing News)
FDA v. Google & Those 14 Infamous Warning Letters
Wed, 18 May 2011 17:54:05 +0100
Ready for a good conspiracy theory? FDA's Infamous 14 Warning Letters Regarding Search Ads were a Ploy to Force Google into a $500M DOJ Settlement of a Case Involving Illegal Online Pharmacy Ads. FDA's warning letters may have been a "shot across Google's bow," intended to force Google to halt its acceptance of ads from "illegal" online pharmacies. Read the full conspiracy theory here (Source: Pharma Marketing News)
Challenges of Regulating Mobile Medical Apps
Wed, 18 May 2011 17:52:24 +0100
Legal and Regulatory Issues You Should Know About. A conversation with Joseph Kim, MD, MPH, VP of Medical Affairs and Technology at Medical Communications Media, Inc., about the rapid development of mobile medical applications and the legal and regulatory issues that physicians, patients, and pharma developers/sponsors should be aware of. (Source: Pharma Marketing News)
SURVEY: Potential for Bias in Commercially Supported CME
Tue, 10 May 2011 10:59:12 +0100
Please take 2 minutes to answer a few short questions relating to potential bias in continuing medical education (CME) programs supported by pharma/medical device companies and how to limit the need for industry funding of CME. (Source: Pharma Marketing News)
SURVEY: Use of Twitter by Pharma Company Employees
Fri, 29 Apr 2011 21:04:14 +0100
More and more pharmaceutical company employees are using Twitter. Many are using personal Twitter accounts and some also are responsible for corporate Twitter accounts. These employees can be influential ambassadors among the public and have an opportunity -- maybe even a responsibility -- to help improve the company's reputation. Please complete this survey and indicate which Pharmaguy Twitter Pioneers you follow and to provide your opinions about the use of Twitter by the drug industry and by employees of the industry. (Source: Pharma Marketing News)
Physicians Favor Brands With a Compelling Adherence Program
Fri, 29 Apr 2011 21:01:26 +0100
This article summarizes the results of a survey of physicians designed to assess the value of various adherence solutions -- including HealthPrize -- and the potential of these solutions to influence physicians' prescribing behavior. (Source: Pharma Marketing News)
FDA's Bad Ad Program is "Phoniest Thing Ever!"
Thu, 28 Apr 2011 21:01:56 +0100
So says Jerry Roth, president of Sanford, Fla.-based Hill Dermaceuticals. His company received the ONLY letter from the FDA as as a result of a complaint received via DDMAC's (Division of Drug Marketing, Advertising, and Communication) Bad Ad Program. Mr Roth claims DDMAC acted on a complaint filed by "a doctor for another [competing] company," which is interesting because so many -- perhaps up to 80% -- of "prescribers" are employed directly or indirectly by pharmaceutical companies. Is the BadAd program biased, ineffective, not worth the cost? (Source: Pharma Marketing News)
FDA Plans to Test New Standard for Easy to Understand Rx Labels
Thu, 28 Apr 2011 21:01:08 +0100
In an effort to make Rx drug package inserts easier to read and understand -- and perhaps to save money on printing costs -- the FDA is planning to test single-page consumer information sheets that would replace the multi-page package inserts and medication guides widely used in retail pharmacies. (Source: Pharma Marketing News)
A New Estimate of Drug Development Cost
Thu, 28 Apr 2011 21:00:29 +0100
A conversation with Jacqueline Thong, co-founder and CEO of Ubiqi Health, about disease management mobile applications and how pharma marketers can leverage mobile health apps to engage with and learn from patients. (Source: Pharma Marketing News)
Implications of Facebook's Page Commenting Changes
Thu, 28 Apr 2011 20:59:49 +0100
Turning Off Comments May Be a Problem. A conversation with Matthew Snodgrass, Social Media Director at WCG, about Facebook's planned changes to its "whitelisting" policy and its implications for pharmaceutical marketers. (Source: Pharma Marketing News)
The Changing Role of Pharma Sales Reps
Sun, 17 Apr 2011 13:15:28 +0100
This article is a summary of an interview of Nancy Lurker, CEO of PDI, Inc., which provides promotional outsourced services to healthcare companies. (Source: Pharma Marketing News)
Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma
Fri, 15 Apr 2011 13:15:14 +0100
The Brits have won the race to issue social media guidance for the drug industry! The Prescription Medicines Code of Practice Authority (PMCPA), which oversees the self-regulatory code of the Association of the British Pharmaceutical Industry (ABPI), just published "informal guidance" providing the drug industry advice on how to use online communications. Read this article to learn more about these guidelines. (Source: Pharma Marketing News)
Phil Mickelson is Now Regulated by FDA
Fri, 15 Apr 2011 13:13:55 +0100
Recall that last summer Phil Mickelson was quoted in the press as saying he was treating his Psoriatic Arthritis with ENBREL. He was also quoted as saying: "I have no aches and pains. My back feels great. I feel stronger and more flexible than I've ever been." Now that he is featured in ENBREL TV ads, his commercial speech is regulated by the FDA. What is he allowed to say now about his treatment? For the answer, read this article. (Source: Pharma Marketing News)
Ad Dollars Follow Eyeballs to Web
Fri, 15 Apr 2011 13:13:00 +0100
Internet advertising revenue in the United States totaled $26.0 billion for the full year of 2010, whereas ad revenue earned by newspapers was $22.8 billion, according to a PwC/IAB report. Read this article to see more data & charts from this report, plus a "guesstimate" for how much pharma spends on Web advertising. (Source: Pharma Marketing News)
Podcast: Mining Mobile Health App User Data
Fri, 15 Apr 2011 13:11:50 +0100
A conversation with Jacqueline Thong, co-founder and CEO of Ubiqi Health, about disease management mobile applications and how pharma marketers can leverage mobile health apps to engage with and learn from patients. (Source: Pharma Marketing News)
SURVEY: Use of Twitter by Pharma Company Employees
Fri, 15 Apr 2011 13:10:32 +0100
More and more pharmaceutical company employees are using Twitter. Many are using personal Twitter accounts and some also are responsible for corporate Twitter accounts. These employees can be influential ambassadors among the public and have an opportunity -- maybe even a responsibility -- to help improve the company's reputation. Please complete this survey and indicate which Pharmaguy Twitter Pioneers you follow and to provide your opinions about the use of Twitter by the drug industry and by employees of the industry. (Source: Pharma Marketing News)
Adverse Event Reporting: A Missed Opportunity
Fri, 01 Apr 2011 14:15:20 +0100
When asked what the # 1 concern pharmaceutical marketers have regarding using social media, the adverse event reporting (AER) boogey man is cited most often. The urge to avoid this boogey man at all costs may have more to do with CEO compensation that with fears of rank-an-file marketers. (Source: Pharma Marketing News)
FDA Promises Still More Guidance! This Time It's Mobile.
Wed, 30 Mar 2011 13:15:08 +0100
"The Food & Drug Administration is planning to release guidance for mobile medical applications in 2011, according to Center for Devices and Radiological Health director Dr. Jeffrey Shuren." At issue is kind of mobile medical applications must be approved as medical devices. So far, FDA has approved only two mobile applications. Meanwhile, many pharmaceutical marketers are developing mobile apps such as Janssen's "Psoriasis" app for the iPhone and iPad. Is this app a medical device that requires approval by the FDA? (Source: Pharma Marketing News)
Physicians Favor Brands with Compelling Adherence Platform
Wed, 30 Mar 2011 13:14:33 +0100
A conversation with Katrina S. Firlik, M.D., Chief Medical Officer, and John Ruvane, Vice President, Sales and Business Development, HealthPrize, highlighting results of an independent physician survey that suggests HealthPrize's patient adherence program can sway physician prescribing preferences. (Source: Pharma Marketing News)
Are Sales Reps as "Useful" as PhRMA Wants Us to Believe?
Wed, 30 Mar 2011 13:14:02 +0100
"New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers" is the main point PhRMA (Pharmaceutical Research and Manufacturing Association - the industry trade association) emphasized in its press release regarding a survey of physicians it sponsored. PhRMA also pointed out that nearly 9 out of 10 physicians considered company-sponsored peer education programs to be "up-to-date, useful and reliable." What else does the survey reveal about the value of sales reps? (Source: Pharma Marketing News)
Pharma TeleWeb e-Detailing
Wed, 30 Mar 2011 13:12:40 +0100
This article summarizes Eli Lilly's European experience using TeleWeb e-detailing, which combines a personal sales rep phone call with Web site surfing. (Source: Pharma Marketing News)
Evidence-Based Pharma Marketing
Sat, 19 Mar 2011 12:50:23 +0100
For marketing professionals, market access is the key to success. Doctors, payers and consumers are asking for value based on evidence. Being able to prove the value of a particular product may be the best method for increasing sales. Pharma marketing executives need the tools and knowledge necessary to use scientific and health outcomes data for proving product value and gaining market access. (Source: Pharma Marketing News)
Method Acting for Real Patients
Thu, 10 Mar 2011 13:49:12 +0100
The pharmaceutical industry can scrap expensive, custom-designed, standalone video Web sites, post videos to YouTube instead, and save money. Even more money can be saved by using real patients in these videos. But can patients be convincing actors? (Source: Pharma Marketing News)
Pharma Twitter Pioneers Recognized
Thu, 10 Mar 2011 13:47:48 +0100
This article is an introduction to the first round of members of this group. (Source: Pharma Marketing News)
Will Critics Kill Pharma's Social Media Golden Egg Laying Goose?
Wed, 23 Feb 2011 18:42:53 +0100
The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media. (Source: Pharma Marketing News)
Phil Mickelson "Opens Up" to Arthritis Today Magazine
Wed, 23 Feb 2011 18:42:34 +0100
Top pro golfer Phil Mickelson is featured on the cover and inside story of the Mar-April 2011 issue of Arthritis Today magazine. In the story, Mickelson's remarks are more balanced now that he is a paid ENBREL spokesperson. (Source: Pharma Marketing News)
AstraZeneca Hosts "Take on Depression" Facebook Discussion
Wed, 23 Feb 2011 18:41:38 +0100
In an ongoing investigation by "Pharma SM Detective", AstraZeneca's "Take on Depression" FaceBook unbranded discussion application was found to include the "seroquel" brand name in its URL. Further investigation disclosed other interesting aspects of AZ's #TakeonDepression campaign. (Source: Pharma Marketing News)
AstraZeneca Hosts Twitter Chat & World Does NOT End!
Wed, 23 Feb 2011 18:41:09 +0100
Despite dire predictions of "PR failure," the #rxsave Twitter chat hosted by @AstraZenecaUS on 15 February 2011 was a great success, which is pharma social media speak for "did not crash and burn." (Source: Pharma Marketing News)
Google's New OneBox Rx "Ads" Steal Clicks
Wed, 23 Feb 2011 18:40:45 +0100
Data suggest that Google's OneBox NIH Rx ads "effectively reduces organic search visitation driven to pharma sites pushing the traffic to NIH content instead. (Source: Pharma Marketing News)
HCP Marketing Beyond the Physician
Wed, 23 Feb 2011 18:40:13 +0100
This article reviews the issue and includes tips for marketing to NPs and PAs. (Source: Pharma Marketing News)
GSK's U.S. Sales Reps "Europeanized"
Thu, 17 Feb 2011 16:29:23 +0100
GSK's sales "reps" will no longer receive commissions "based on their ability to push prescriptions. (Source: Pharma Marketing News)
Good Promotion Practices Alliance
Thu, 17 Feb 2011 16:29:09 +0100
Plenty of attention being paid to pharmaceutical marketing fraud and abuse cases in blogs and in the general media. But there hasn't been much attention paid to good compliance solutions or best practices. That's the mission of the Good Promotion Practices Alliance (GPP), which is co-sponsored by Reprints Desk and Prolifiq Software. (Source: Pharma Marketing News)
The Socialisation of the Internet is Bogus
Thu, 17 Feb 2011 16:28:54 +0100
How as an industry can we influence the exchange of ideas and information if we are not prepared to be where our audience and communities exist? (Source: Pharma Marketing News)
FDA's Abrams Spends 4 Minutes Discussing Social Media Guidance at ePharma Summit!
Thu, 17 Feb 2011 16:28:22 +0100
Tom Abrams, the Head of FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC), apparently believes Twitter and YouTube are passing fads. (Source: Pharma Marketing News)
Breaking the 140-character Limit of Twitter Opens the Door to FDA-Compliant Branded Tweets
Thu, 17 Feb 2011 16:27:49 +0100
Deck.ly has enormous potential for pharmaceutical marketers who have been chaffing at the bit to post meaningful branded messages via Twitter but who have been stymied by lack of guidance from FDA regarding how to provide fair balance within the 140-character limit of Twitter. (Source: Pharma Marketing News)
Elitist Pharmaceutical Marketing
Wed, 19 Jan 2011 15:39:50 +0100
Why do pharma marketers spend millions of dollars on celebrities like Phil Mickelson to promote products to an elite audience such as golfers when the money can better be spent reaching the poorer masses huddled around their TVs watching Dancing with the Stars? (Source: Pharma Marketing News)
Deal with Lack of Regulations by Developing Best Practices
Wed, 19 Jan 2011 15:39:22 +0100
The pharma industry must continue to deal with a LACK of guidance from the FDA regarding social media communications. That's fine, because guidance or no guidance, best practices in social media communications is still evolving. A few pharma companies are ahead of the pack in that regard. (Source: Pharma Marketing News)
Amgen Blows Its Marketing Budget on Phil Mickelson Campaign
Wed, 19 Jan 2011 15:38:05 +0100
Whether or not Phil was on the pharma payroll when he revealed he was taking ENBREL to treat his psoriatic arthritis and also claimed "I have no aches and pains. My back feels great. I feel stronger and more flexible than I've ever been" is a moot point. However, payng for Phil may have blown Amgen's patient-support/marketing budget. (Source: Pharma Marketing News)
FDA Says There are "No simple solutions" to Speed Up Its Regulatory Guidance Process
Wed, 19 Jan 2011 15:34:53 +0100
Timeliness of issuing FDA guidance was top of mind in 2010 for the many pharma marketers who waited for social media/internet draft guidance that the FDA hoped would be released before the end of 2010. FDA took note of several comments it received stating that the timeliness of its regulatory guidance process must be improved. In response, an FDA Transparency Task Force report says that "there are no simple solutions to such problems." (Source: Pharma Marketing News)
Getting Market Research Right in India & China
Wed, 19 Jan 2011 15:30:43 +0100
This is the last in a series of three articles highlighting points made by Kantar Health executives in a recent webinar titled, "Getting It Right in the Emerging Markets: Identifying the opportunities and avoiding the pitfalls in conducting market research in new geographies." (Source: Pharma Marketing News)
Strategies for Marketing Compliance
Wed, 19 Jan 2011 15:28:48 +0100
This article offers a few thoughts from a physician's point. (Source: Pharma Marketing News)
Welcome to the 2010 Pharma Marketing YearBook
Sun, 16 Jan 2011 17:31:25 +0100
Welcome to Volume 10, Issue No. 1 (Jan 12, 2011) of Pharma Marketing News. This issue of Pharma Marketing News is devoted to the Pharma Marketing Yearbook (PMY), which is a commemorative record of pharmaceutical marketing issues and highlights of the past year. (Source: Pharma Marketing News)
Events I Witnessed, News You Made, & People We Met
Thu, 13 Jan 2011 18:10:36 +0100
The year 2010 was all about me. By 'me' I mean Pharmaguy, which is the Twitter handle and Facebook name of John Mack, Editor and Publisher of Pharma Marketing News. It's all about YOU too! This is where you can 'sign' the 2010 Pharma Marketing Yearbook and and document that you were part of it all. (Source: Pharma Marketing News)
Pharma Companies Behaving Badly
Thu, 13 Jan 2011 17:55:15 +0100
Every year without fail there are revelations about pharmaceutical companies behaving badly -- companies that have been charged with crimes such as making kickbacks to physicians, engaging in Medicare and Medicaid fraud, promoting products off label to physicians or companies that are called to testify before Congress about sub par manufacturing practices. 2010 seems to be unique in the number of companies behaving badly. (Source: Pharma Marketing News)
Welcome to the 2010 Pharma Marketing YearBook™
Thu, 13 Jan 2011 17:54:47 +0100
Welcome to Volume 10, Issue No. 1 (Jan 12, 2011) of Pharma Marketing News. This issue of Pharma Marketing News is devoted to the Pharma Marketing Yearbook (PMY), which is a commemorative record of pharmaceutical marketing issues and highlights of the past year. (Source: Pharma Marketing News)
Pharma Spending on Internet, DTC, and Docs
Thu, 13 Jan 2011 17:44:40 +0100
How much money the pharmaceutical industry spends on Internet marketing, direct-to-consumer advertising, and physician detailing are always topics of interest and 2010 was no exception. 2010 was, however, a turning point in bringing more attention to payments made to physicians for speaking, consulting, and research. (Source: Pharma Marketing News)
Pharma Social Media Trials & Tribulations
Wed, 12 Jan 2011 14:30:28 +0100
Social media occupied a good deal of our attention in 2010 and many of the pharma people Pharmaguy met and interacted with in 2010 are involved in social media campaigns in one way or another. (Source: Pharma Marketing News)
Pharma's 2010 Christmas Wish List for Santa
Fri, 17 Dec 2010 12:18:40 +0100
Included on the list: FDA social media guidelines (Duh!), pharma-friendly biosimilar regulations, increased drug pipeline, and others that you can read about in this OpEd piece, which provides background on these issues, as well as useful data and links to resources. Santa may not be able to solve all these problems, but it's worth a shot! (Source: Pharma Marketing News)
New Media Privacy Issues & Online Health Marketing
Fri, 17 Dec 2010 12:11:24 +0100
This article is a summary of a Center for Digital Democracy complaint filed with the FTC and a review of the issues. The article also includes a compilation of more than two dozen 'innovative" online marketing products/solutions mentioned in the complaint. (Source: Pharma Marketing News)
Capturing & Reporting HCP-Related Meeting Spending
Tue, 30 Nov 2010 16:45:55 +0100
This article is a summary of a Webinar by StarCite, which defined what pharma marketers and meeting planners need to know when it comes to meetings-related HCP reporting. (Source: Pharma Marketing News)
Getting Market Research Right in the Middle East
Tue, 16 Nov 2010 20:31:58 +0100
If the Middle East was a single country, it would be the fifth largest market in the world in terms of GDP. The sales of pharmaceuticals in the Middle East surpasses 20 billion US dollars per year and is growing by 10 to 15% per year. This is the second in a series of three articles highlighting points made by Kantar Health executives in a recent webinar titled "Getting It Right in the Emerging Markets: Identifying the opportunities and avoiding the pitfalls in conducting market research in new geographies." (Source: Pharma Marketing News)
Pharma Collaboration with Online Patient Opinion Leaders
Wed, 10 Nov 2010 15:17:54 +0100
It's time to determine the issues involving transparency and conflicts of interest that may arise if and when pharma companies pay individual "Patient Opinion Leaders" (POLs) to help manage their engagement with patients online. What best practices should govern pharma's collaboration with POLs? Should the industry develop guidelines for their interactions with POLs? This OpEd is a call for action and input from readers regarding these issues and questions. (Source: Pharma Marketing News)
Physician-Generated Content on Social Media Sites
Wed, 10 Nov 2010 14:56:45 +0100
This article highlights results of a survey of physician members of DocCheck, a leading European physician online social network and portal site. The survey assessed the type of networks used, the frequency of posting, motivation for posting, estimation of network usage, relevance of content posted and an evaluation of the importance of online physician-generated content in the future. (Source: Pharma Marketing News)
Getting Market Research Right in Emerging Markets
Thu, 28 Oct 2010 13:55:10 +0100
This is the first in a series of articles summarizing highlights from a recent webinar focused on getting market research right in emerging markets. It features experts from Kantar Health, a global consultancy and marketing insights organization that was formed in 2009 by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment. (Source: Pharma Marketing News)
Digital Pharma Is Alive and Well in Europe!
Fri, 15 Oct 2010 17:30:25 +0100
These highlights from the 2010 DigiPharm EU conference summarizes presentations made by marketing specialists from Lundbeck, Janssen, GSK, Schering Plough, Boehringer Ingelheim, Pfizer, Genzyme and Merck Serono. It's a summary of the best current practices and a glimpse at how EU pharma companies are driving digital marketing and communications forward. (Source: Pharma Marketing News)
Integration of Custom Media into the Marketing Mix
Wed, 13 Oct 2010 10:38:25 +0100
This article summarizes a discussion with Abraham Ogden, the Director of Book Publications for the American Diabetes Association, about integrating ADA's custom publications into the pharma marketing mix. (Source: Pharma Marketing News)
Social Media and the Limitations of Disease Awareness Campaigns
Tue, 12 Oct 2010 17:30:46 +0100
Disease awareness (DA) campaigns have limitations that even well-executed social media campaigns cannot overcome. (Source: Pharma Marketing News)
Closed-Loop Patient Education
Thu, 23 Sep 2010 13:09:43 +0100
MedTera recently partnered with HealthPrize Technologies, a web-based software company that motivates people to fill and stay on prescription medications, to bring together MedTera's online and offline educational resources and HealthPrize's online, interactive platform to educate people about their chronic diseases and incentivize them for taking their medications as prescribed. (Source: Pharma Marketing News)
Eyes on the Adherence Prize
Thu, 23 Sep 2010 13:08:51 +0100
This article provides details about the HealthPrize's innovative, compelling approach to solving one of pharma's most perplexing puzzle: how to improve medication adherence. Included is a summary of a Pharma Marketing Talk podcast interview of Tom Kottler, CEO, and Katrina S. Firlik, M.D., Chief Medical Officer, HealthPrize. (Source: Pharma Marketing News)
Solving the Adherence Problem in Economic Hard Times
Wed, 01 Sep 2010 16:57:04 +0100
Medication non-adherence -- ie, patients not taking their medications as prescribed by their doctors -- is one of the most significant problems in healthcare. It is an even bigger problem during economic hard times as more people cut back their medications to save money. There are many facets to this problem, which cannot simply be solved by lowering drug costs. This month's Pharma Marketing News includes several articles that feature innovative solutions to the adherence problem. In preparation for these articles, several experts will be guests on the Pharma Marketing BlogTalkRadio Show during the month of September. (Source: Pharma Marketing News)
Pharma, Physicians, and Sermo
Wed, 01 Sep 2010 16:55:56 +0100
This article provides an overview of Sermo's new Client Center and summarizes a Pharma Marketing Talk podcast interview of with Daniel Palestrant, Sermo's Founder and Chief Executive Officer. (Source: Pharma Marketing News)
Just-in-Time Publishing
Thu, 05 Aug 2010 13:22:46 +0100
Beginning with this issue a new publication plan -- the Just-in-Time Publishing plan -- is being implemented. This new publication schedule will benefit readers with more timely release of valuable information. It will benefit advertisers too. Read this OpEd piece to find out the details. (Source: Pharma Marketing News)
The Pharmaguy Next Door
Thu, 05 Aug 2010 13:22:46 +0100
John Mack, a.k.a. pharmaguy on Twitter, answers questions about his background and provides his opinions on how pharmaceutical companies will use social media in the future. (Source: Pharma Marketing News)
Social Media Leaders Wanted
Thu, 29 Jul 2010 16:34:21 +0100
This article reviews the results of Pharma Marketing News' What's Your Social Media Implementation Plan? survey and announces the details of the Pharmaguy Social Media Pioneer Award. (Source: Pharma Marketing News)
The iPad as a Pharma Marketing Platform
Wed, 28 Jul 2010 14:51:40 +0100
This article summarizes how the iPad is currently being used by the pharmaceutical industry, how it is being adopted by physicians, and what the roadblocks are to using it for eDetailing. (Source: Pharma Marketing News)
Public Relations Communications in the Fast-paced World of Twitter
Wed, 26 May 2010 10:17:02 +0100
When it comes to crisis communications in the faced-paced digital world of blogging and Twitter, pharmaceutical companies have no roadmap to guide them. The J&J/McNeil recall fiasco may be a case study on "how-not-to" manage crisis communications in the faced-paced digital world of blogging and Twitter. Pharma can learn from this case how, crisis or otherwise, one deals with the breakneck pace and two-way, consumer-driven nature of digital communications. (Source: Pharma Marketing News)
Data Mining in the Deep, Dark Social Networks of Patients
Wed, 26 May 2010 10:16:34 +0100
If pharma marketers wish to tap into closed online patient communities that are rich sources of information, they need to pay careful attention to the rules lest they suffer the consequences to their reputations. (Source: Pharma Marketing News)
ePrints NRx for Physician Detailing
Wed, 26 May 2010 10:16:07 +0100
This article describes and summarizes the features and benefits of the Reprints Desk's ePrints NRx solution -- a new scientific article collection service that simplifies the re-use of PDFs by medical marketers, brand managers, and sales professionals. (Source: Pharma Marketing News)
The Changing Pharma Commercial Model in 2010 and Beyond
Wed, 26 May 2010 10:15:29 +0100
This article features a summary of the much anticipated NEW Kantar Health TRI*M annual survey results with physicians across the U.S. and Europe on their service expectations -- plus how they rate 16 Pharma companies on reps, relationships and services. The survey looked not only at PCPs/GPs but also -- for the first time -- at what oncologists expect from the industry. (Source: Pharma Marketing News)
Use of Social Media for Health Purposes in the EU
Fri, 30 Apr 2010 14:54:06 +0100
This article is a summary of the EPG Health Media (part of the IMR International Group) market research report "Social Media and Healthcare," which examines how European doctors, patients/consumers and pharma engage (and seek to engage) with each other. (Source: Pharma Marketing News)
What's Your Social Media Implementation Plan?
Fri, 30 Apr 2010 14:54:06 +0100
Sanofi-Aventis's recent Facebook experience with comments posted to its wall provoked a lot of new thinking about how to manage pharma social networks rather than how the FDA should regulate pharma use of social media. We've just passed a new milestone and entered a pharma social media implementation phase. Are you ready? (Source: Pharma Marketing News)
Moderation Best Practices for Pharma Social Networks
Fri, 30 Apr 2010 14:53:50 +0100
This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices. (Source: Pharma Marketing News)
How to Manage the Online Conversation
Fri, 30 Apr 2010 14:52:21 +0100
This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices. This article presents a summary of a conversation with Jenna Woodul, LiveWorld's EVP and Chief Community Officer, about how pharma companies can manage their social media interactions using technology and credentialed participants. (Source: Pharma Marketing News)
Real Patient Testimonials
Fri, 30 Apr 2010 14:51:42 +0100
This article discusses the potential pitfalls, regulatory issues, and best practices regarding the use of real patient testimonials based on comments collected from a recent survey of readers and other experts. (Source: Pharma Marketing News)
Solving the Social Media Adverse Event Reporting Problem
Wed, 31 Mar 2010 17:57:19 +0100
Many presenters at FDA's November 2009 public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools addressed this problem and offered solutions. Comments submitted to the FDA after the meeting offer more details, which are reviewed in this article. (Source: Pharma Marketing News)
FDA Can Relax. I Did All the Work for Them!
Wed, 31 Mar 2010 17:57:19 +0100
The March 2010 issue of Pharma Marketing News does practically all the work for the FDA in summarizing comments submitted to FDA's docket regarding "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools." (Source: Pharma Marketing News)
Accountability for Pharma Content on Social Media Sites
Wed, 31 Mar 2010 17:56:46 +0100
A substantial portion of drug industry comments submitted to the FDA was devoted to how pharmaceutical companies should be held accountable for a communication about its product(s) and how much control they exert over activities on the Internet and social media. (Source: Pharma Marketing News)
Overcoming Space Limitations in Social Media
Wed, 31 Mar 2010 17:56:06 +0100
This article presents a summary of comments to FDA from the drug industry addressing regulatory concerns when using social media tools associated with space limitations or tools that allow for real-time communications to present product information. (Source: Pharma Marketing News)
Industry and Consumer Advocates Square Off Regarding Social Media
Wed, 31 Mar 2010 17:55:31 +0100
This article presents an overview of the types of organizations that submitted comments versus those that made presentations at the November 2009 public hearing. It also includes general comments from the pharma industry regarding the process by which the FDA should regulate the Internet and social media. Also presented in this article are the comments submitted by consumer advocates and individuals who generally supported more strict regulation across the board. (Source: Pharma Marketing News)
Use of Behavioral Targeting by Pharma Marketers
Thu, 25 Feb 2010 14:15:57 +0100
This article summarizes the results of a survey designed to answer the questions: Should the pharmaceutical industry adopt similar self-regulatory principles that were established by media and marketing trade associations to protect consumer privacy when employing behavioral targeting, Should pharma marketers use behavioral targeting at all?, If they do use it, when is it appropriate? (Source: Pharma Marketing News)
Waiting for Goduidance
Thu, 25 Feb 2010 14:15:57 +0100
It seems like every pharmaceutical marketer is waiting for guidance from the FDA before they do more online marketing and especially more social media marketing. It's like Waiting for Godot -- guidance may never come. What then? Or it could come. Then what? (Source: Pharma Marketing News)
Pharma's Social Media Working Group
Thu, 25 Feb 2010 14:15:48 +0100
This article reviews the Who, What, and Why of Pharma's Social Media Working Group (SMWG) based on a conversation with Mark Gaydos, Senior Director, U.S. Regulatory Affairs Marketed Products at sanofi-aventis, and Cynthia Phillips, Sr Dir Labeling and Promotional Compliance at Millennium Pharmaceuticals. Also covered is an analysis of comments the SMWG submitted to the FDA on how pharmaceutical companies should handle off-label and adverse event posts made on social media sites owned or sponsored by them. (Source: Pharma Marketing News)
Building the "New" Pharma Physician Marketing Model
Thu, 25 Feb 2010 14:15:04 +0100
This article reviews MedTera's HC Professional "Life Long Learning" Platform -- branded integrated physician marketing solutions -- and presents a summary of research on how brand teams see the mix of marketing tactics changing over the next several years. (Source: Pharma Marketing News)
Use of Twitter for Patient Support
Thu, 25 Feb 2010 14:14:14 +0100
This article summarizes a survey that asked respondents to evaluate several ways in which Twitter could be used to improve patient support. (Source: Pharma Marketing News)
Healthcare Communications vs. Pharma Marketing
Wed, 27 Jan 2010 14:30:43 +0100
Whenever someone refers to a pharmaceutical company as a "healthcare company" the hairs on the back of my neck (where I still have some hair) rise up. Are pharmaceutical companies healthcare companies? Should we replace "pharmaceutical marketing" with "healthcare communications?" (Source: Pharma Marketing News)
Pharma Begins to Reveal Payments to Physicians
Wed, 27 Jan 2010 14:30:37 +0100
This article reviews the physician payment lists published by Lilly, Merck, and GSK. The analysis gives us more insight into the fees paid by various companies, how the money was distributed by state and region in the US, and what types of activities (eg, speaker fees vs. consulting fees) physicians were paid to perform. (Source: Pharma Marketing News)
Corporate Reputation in the New Media World
Wed, 27 Jan 2010 14:29:47 +0100
This article summarizes the presentations made at that webinar. (Source: Pharma Marketing News)
Predicting the Future of the Drug Industry
Wed, 27 Jan 2010 14:28:58 +0100
This article reviews the results of the 'Predicting the Future of the Drug Industry: 2010 & Beyond!' survey and provides background on future trends. (Source: Pharma Marketing News)
Pharma's Image Conundrum
Wed, 16 Dec 2009 20:56:19 +0100
Building Brand Loyalty and Consumer Confidence In this guest article, Carla Stratfold, CEO at OnRequest Images, presents several key learnings and best practices that pharmas can follow when building brand and consumer loyalty (Source: Pharma Marketing News)
What's Next from FDA?
Wed, 16 Dec 2009 20:56:19 +0100
Now that the FDA public hearing about regulating drug and medical device promotion on the Internet has come and gone, everyone who has a stake in the issues discussed at that hearing is wondering what the next steps are. Practically everyone believes the FDA will issue some form of guidance for the industry. Here's a list of important questions for FDA from our readers. (Source: Pharma Marketing News)
A Few Things I Learned at FDA's Social Media Hearing
Wed, 16 Dec 2009 20:56:14 +0100
This article presents key takeaways from the FDA hearing, a synopsis of the presentations made by John Mack, Publisher, Pharma Marketing News, at the hearing, a review of Ignite Health's study regarding effectiveness of sponsored links, and the next steps in the process of issuing guidance. (Source: Pharma Marketing News)
Search Advertising Options for Pharma
Wed, 16 Dec 2009 20:55:27 +0100
What to Do While Waiting for Those Guidelines In this article, Julie Batten, eMarketing Manager at Klick Pharma discusses pharma's options for search marketing in this period between the FDA public hearing and when the much anticipated draft and final guidance on the issue is published. (Source: Pharma Marketing News)
Consequences of DTCA
Wed, 16 Dec 2009 20:54:18 +0100
This article focuses on a new study that suggests drug price increases are engineered to cover the costs of Direct-to-Consumer Advertising (DTCA). Drug price trend data from AARP, AHRQ, and prescription drug consumer price index (CPI) are presented. Also, what's the link between DTCA and competition? (Source: Pharma Marketing News)
Risk Mitigation and Its Impact on Pharma Marketing
Thu, 29 Oct 2009 12:45:11 +0100
This article summarizes ParagonRx's ideas about how to develop a REMS that can be a win-win-win situation for you, your product, and the patient. (Source: Pharma Marketing News)
Fear and Loathing in Washington, DC
Thu, 29 Oct 2009 12:45:11 +0100
John Mack, Editor of Pharma Marketing News, will make a presentation in front of the DDMAC at the November, 2009, public hearing on Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. (Source: Pharma Marketing News)
Pharmaceutical Market Access 2010
Thu, 29 Oct 2009 12:43:56 +0100
This article addresses that question. (Source: Pharma Marketing News)
Social Media Adverse Event Reporting Safe Harbors
Thu, 29 Oct 2009 12:43:18 +0100
This article presents ideas for regulatory 'safe harbors' under which pharmaceutical companies would be relieved of the responsibility of monitoring social media for adverse events. Includes a detailed summary of responses to the survey "FDA Regulation of Drug & Device Promotion via the Internet & Social Media" regarding social media adverse event monitoring, processing, challenges, and uncertainties. (Source: Pharma Marketing News)
Pharmaguy's Twitter Followers
Tue, 22 Sep 2009 20:13:32 +0100
This article summarizes the findings of a survey of over 400 of @pharmaguy's followers. The results will give you a better idea why people who are interested in the pharmaceutical industry use Twitter and what they expect to get out of it. (Source: Pharma Marketing News)
Let's Respond to FDA's Questions Regarding Its Regulation of Social Media
Tue, 22 Sep 2009 20:13:32 +0100
The FDA is requesting the public to submit comments to a series of specific questions regarding the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. These questions are included in a new survey created by Pharma Marketing News. Let's use this survey to help educate the FDA on the issues. (Source: Pharma Marketing News)
Pharma-Sponsored Medical Ghostwriting
Tue, 22 Sep 2009 20:12:50 +0100
What the Ghosts Have to Say About It Pharma Marketing News surveyed readers to determine if medical journal articles sponsored and ghostwritten by drug companies are a legitimate part of marketing to physicians and to get opinions on various other issues raised in the press about ghostwriting. (Source: Pharma Marketing News)
What If There Were No Rules in Pharma Marketing?
Tue, 22 Sep 2009 20:12:07 +0100
Be Sure Not to Cut Off the Ends of Your Ham What If There Were No Rules in Pharma Marketing? There's no FDA, no DDMAC, no FTC. Your company guidelines and rules don't exist and your regulatory and legal teams have been disbanded. It's a free-for-all and there are no rules. The question is: what would you do? (Source: Pharma Marketing News)
Waning Pharma Support of CME
Thu, 06 Aug 2009 14:16:52 +0100
This article summaries Congressional testimony, ACCME data, and results of a reader survey on this topic. (Source: Pharma Marketing News)
Social Media & the Truncated News Pyramid
Thu, 06 Aug 2009 14:16:52 +0100
PR people are used to issuing press releases to a few journalists at the top of the traditional news pyramid. When the top was blown off by the social media revolution, these professionals had no proven mechanism by which to reach the many thousands of bloggers at the BOTTOM of the pyramid -- until now. (Source: Pharma Marketing News)
Social Communications in Healthcare
Thu, 06 Aug 2009 14:15:53 +0100
This article provides several summaries written by the roundtable discussion leaders themselves. (Source: Pharma Marketing News)
Owning the Prescription Pad
Thu, 06 Aug 2009 14:14:54 +0100
This article presents such a model developed by TNS Healthcare, A Kantar Health Company. (Source: Pharma Marketing News)
Whither Twitter for Pharma?
Thu, 09 Jul 2009 00:59:31 +0100
Twitter is growing by leaps and bounds! Which makes Twitter attractive to pharmaceutical marketers. But can pharma's Twitter campaigns reach a significant number of people? Will they reach the right people? Is Twitter even appropriate for branded messages? (Source: Pharma Marketing News)
FDA Draft Guidance on Risk Communication
Thu, 09 Jul 2009 00:59:28 +0100
The recent FDA Draft Guidance for Industry, Presenting Risk Information in Prescription Drug and Medical Device Promotion guidance focuses almost exclusively on print and broadcast promotional ads. It is possible, however, to apply some of FDA's "thinking" to certain kinds of Internet ads such as search engine paid ads. (Source: Pharma Marketing News)
How Should Pharma Engage in Social Networks?
Thu, 09 Jul 2009 00:58:18 +0100
This article summarizes the results of that survey. (Source: Pharma Marketing News)
Pharma Marketers Dive Deeper Into Social Media
Thu, 09 Jul 2009 00:57:17 +0100
This article focuses in some detail on three interesting pharma social media initiatives: (1) Procter & Gamble's Asacol Community for Ulcerative Colitis Patients; (2) Novo Nordisk's Levemir-branded Race With Insulin Twitter account; and (3) UCB's sponsored epilepsy community on the PatientsLikeMe website. (Source: Pharma Marketing News)
Report from the Social Pharmer "Unconference"
Thu, 30 Apr 2009 19:24:15 +0100
This article summarizes key presentations made at the April 21, 2009, Social Pharmer 'unconference' where leading pahram social media proponents presnted ideas on how the industry can overcome the barriers. (Source: Pharma Marketing News)
Social Media: Opportunity or Nightmare?
Thu, 30 Apr 2009 19:24:15 +0100
The April 2009 issue of Pharma Marketing News is focused on social media, patient empowerment (which is powered by social media), and the constraints of regulation. This OpEd presents some background on social media usage and discusses how the articles in this issue are related. (Source: Pharma Marketing News)
Socially Challenged Pharma
Thu, 30 Apr 2009 19:23:46 +0100
This article summarizes the recent Digital Pharma Europe congress where it was the time right to see that European pharma marketers are also interested in new/social/digital media in pharma, but may be more constrained by regulators than their brethern in the US. (Source: Pharma Marketing News)
The Empowered Patient
Thu, 30 Apr 2009 19:23:04 +0100
This article presents a case for the drug industry to adopt a patient-centric model in which pharma companies can develop unique expertise in decoding the behavior, needs, motivations of empowered patients and then use this knowledge as the basis for helping healthcare professionals and payers to put into place programs that achieve better patient outcomes. (Source: Pharma Marketing News)
Developing Guidelines for Pharma's Use of the Internet & Social Media
Thu, 30 Apr 2009 19:22:10 +0100
A Call for a Public Hearing at FDA Shouldn't we make sure that when it comes time for the FDA to actually create a guidance document on social media that it does it with input from ALL stakeholders? Survey results. (Source: Pharma Marketing News)
New Privacy Rules in Economic Stimulus Law
Mon, 30 Mar 2009 15:09:41 +0100
This article reviews the medical privacy restrictions included in the American Recovery and Reinvestment Act, which President Obama signed into law on Feb. 17, 2009, and discusses the impact these restrictions might have on pharmaceutical marketing. (Source: Pharma Marketing News)
Syndication is da Bomb!
Mon, 30 Mar 2009 15:09:41 +0100
Many publishers, including Pharma Marketing News, and even the FDA syndicate content via RSS feeds. In this UpFront piece, John Mack, Pharma Marketing News Editor, reviews how PMN uses RSS feeds to provide content to our readers from a wide variety of sources including the FDA, PhRMA, major news media, blogs, trade publications, etc. (Source: Pharma Marketing News)
FDA's Use of Social Media
Mon, 30 Mar 2009 15:09:01 +0100
This article describes FDA's social networking initiatives in context of these questions. (Source: Pharma Marketing News)
Will Healthcare be Rationed or Rational?
Mon, 30 Mar 2009 15:08:21 +0100
In this article, Kim Slocum, former Director, Strategic Planning & Business Development at AstraZeneca describes several alternative future health care system scenarios and makes a case for the industry to support Comparative Effectiveness Research or CER. (Source: Pharma Marketing News)
Pharma's Bad Rep or Bad Rap
Mon, 30 Mar 2009 15:08:06 +0100
This article summarizes the results of the "How to Earn Back the Public's Trust" survey hosted by Pharma Marketing News between February 4, 2009 and March 14, 2009 , including selected comments from respondents and other commentators. (Source: Pharma Marketing News)
Sales Force Effectiveness Metrics
Tue, 03 Mar 2009 19:02:07 +0100
This article summarizes a recent discussion between eyeforpharma's Editor Lisa Roner and Hans Nagl, Promotion Response Modelling Manager, Shire, about how the current economy and changing pharma landscape is impacting program effectiveness measures. (Source: Pharma Marketing News)
Pledge to Subscribers & Advertisers
Tue, 03 Mar 2009 19:02:07 +0100
Pharma Marketing News and the entire Pharma Marketing Network comprised of Web sites, blogs and social networking discussion boards pledges to help its readers, subscribers and advertisers do well during this tough time for the economy. Lower prices, less advertising, more free exposure, and different channels of communication are some of the changes we plan to implement. (Source: Pharma Marketing News)
The New Rules of Marketing & PR
Tue, 03 Mar 2009 19:01:14 +0100
Book Review and Insights for Pharma The pharmaceutical industry must find ways to utilize the new media tools that other industries use while ensuring compliance with FDA regulations. The good news is we can! The author summaries the content of the book and offers practical guidelines for the pharma marketers. (Source: Pharma Marketing News)
Building the Optimal Service Model
Tue, 03 Mar 2009 19:00:28 +0100
This article presents a summary of a recent TNS Healthcare webinar and personal conversations with presenters conducted beforehand. Included are NEW research results about how US and European physicians rate pharmaceutical companies against a number of customer value points that are important in achieving success with the new sales model. (Source: Pharma Marketing News)
The View From ePharma Summit
Tue, 03 Mar 2009 18:59:38 +0100
This article is a compilation of summaries of presentations made at the 2009 ePharma Summit. Included are highlights posted to the ePharma Summit and other blogs during the conference and insights on epharma marketing issues provided by several conference speakers and attendees. (Source: Pharma Marketing News)
The Hypocrisy of Healthcare Marketing Restrictions
Wed, 28 Jan 2009 15:55:45 +0100
Stand Up for Healthcare Marketing Free Speech! So says Dmitriy Kruglyak of Trusted.MD Network who thinks PhRMA has caved in to hypocritical attacks by the media and other critics of the industry. (Source: Pharma Marketing News)
Is There Life After Pharma?
Wed, 28 Jan 2009 15:55:45 +0100
Before the year is out you probably will know one or two or more people who are no longer employed in this industry. These people may have several employment options, but they may no longer be sought after by any company related to the drug industry. So, what is life like after pharma? (Source: Pharma Marketing News)
FDA Finalizes Guidance on Distribution of Reprints
Wed, 28 Jan 2009 15:54:35 +0100
This article outlines the major provisions of the guidance and helps you learn how to make iy work for your company. (Source: Pharma Marketing News)
The ePharma Pioneer Club™
Wed, 28 Jan 2009 15:53:46 +0100
Convincing Pharma Marketers to Engage in "e" An EXCLUSIVE, members-only Facebook Group through which pharmaceutical eMarketing experts 'meet' to discuss and exchange views on how to advance the use of the Internet and other technologies in pharmaceutical marketing, sales, and communications. (Source: Pharma Marketing News)
The Future of DTC Advertising
Wed, 28 Jan 2009 15:52:36 +0100
A bad economy, anemic drug pipelines, and draconian regulations -- is a perfect storm brewing? We poll readers and experts to help predict the immediate future of DTC advertising and to get some insights. (Source: Pharma Marketing News)
Reforming the FDA: It All Starts with a New Commissioner!
Thu, 18 Dec 2008 21:15:53 +0100
This article summarizes the results of a recent survey in which varioous stakeholders voted for their choice. (Source: Pharma Marketing News)
Prepare or Die!
Thu, 18 Dec 2008 21:15:53 +0100
Usually, at this time of the year, editors look back on the major stories of the past year. Let’s be different and look forward to the New Year! Not that it’s going to be any more pleasant than the old year; it’s just better to prepare for what’s coming than to reminisce about what’s come and gone. (Source: Pharma Marketing News)
Critical: What Daschle Plans to Do About the Healthcare Crisis
Thu, 18 Dec 2008 21:12:26 +0100
This article summarizes the main points Daschle makes and reveals his plan for 'fixing' the problem. (Source: Pharma Marketing News)
Patient Assistance Program Rankings
Thu, 18 Dec 2008 20:02:51 +0100
In a syndicated study that identifies what physicians perceive to be the top pharmaceutical PAPs in the industry, Market Strategies -- a research and strategic consulting firm -- identified how PAP image influences overall corporate image among oncology physician specialists, what performance measures drive a pharmaceutical company's PAP image, and which companies are perceived as having the best PAP. (Source: Pharma Marketing News)
The Changing Policy Landscape
Thu, 18 Dec 2008 20:01:12 +0100
The two traditional means by which pharmaceutical marketers have relied on for many, many years to encourage the uptake of new pharmaceutical products -- direct-to-consumer (DTC) advertising and physician marketing -- are about to change. Prepare now for the coming FDA and pharmaceutical marketing reforms. (Source: Pharma Marketing News)
Measuring & Communicating eSuccess: Strategy First, YouTube Later... Maybe
Thu, 20 Nov 2008 14:44:25 +0100
This article is a review of a presentation by Aaron Uydess, Senior eMarketing Manager at Novo Nordisk, made at Eye for Pharma's 3rd eCommunication and Online Marketing Summit held October 23-24, 2008, in Boston, Massachusetts. Uydess presents a best-in-class approach to developing online plans that align with strategy, reduce silos, and measure and merchandise digital strategies across a pharmaceutical marketing organization. (Source: Pharma Marketing News)
Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging Strategies
Thu, 20 Nov 2008 14:43:11 +0100
In today's competitive market, pricing and reimbursement strategies are key to maximizing brand success and ROI. Because every country's healthcare system is different-and every product situation is unique-every brand requires a specific access plan, tailored to each market. And you must support each plan with effective messaging that ensures strong product acceptance and uptake. Experts from TNS Healthcare spoke on this issue in a recent webinar and during an exclusive interview with Pharma Marketing News. (Source: Pharma Marketing News)
Free Drug Samples: The Sales Rep's Last Great Hope?
Thu, 20 Nov 2008 14:42:53 +0100
Should free drug samples be banned? The new PhRMA Code on Interactions with Healthcare Professionals bans free pens and out-of-office lunches, but it doesn't ban samples. Many sales consider free drug samples an important marketing tactic that they can employ to gain access to physicians. In 2005, the pharmaceutical industry distributed more than $18 billion worth of drug samples. But critics are concerned that drug samples increase costs, raise questions about the appropriateness of treatment choices, and create real or perceived conflicts of interest in the medical profession. (Source: Pharma Marketing News)
Time for a New & Improved FDA Commissioner
Thu, 20 Nov 2008 14:39:05 +0100
There is no doubt that Dr. Andrew von Eschenbach, the current FDA Commissioner, will soon be leaving the FDA and will not allow the door to hit him on the ass on the way out. Who will Obama nominate to replace von Eschenbach? There are plenty of special interest groups that would like to influence his decision. I wonder how Obama will balance all these diverse interests to pick the right person? Whoever the nominee is, the new FDA Commissioner will also need to balance competing interests (Source: Pharma Marketing News)
 
 
© 2009 Rx Celebs, LLC